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ETIOLOGICAL CHARACTERIZATION OF EMERGENCY DEPARTEMENT ACUTE 
POISONING 
AbdMalek S. Khlifi, M.D. 
ABSTRACT 
 
 Poisoning is frequently associated with psychological and physiological co-
morbidities that can be assessed in order to improve patients’ management and reduce 
cost. The primary objective of this study is to conduct a review of emergency department 
(ED) poisonings to characterize its demographics and assess associated co-morbidities. 
The second objective is to explore correlation between personal history of diseases and 
poisonings. Predictors for poisonings and its outcomes were investigated and risk factors 
for suicidal poisoning and how it relates to mental illnesses were explored.  Six hundred 
and forty nine cases admitted to ED between 2004 and 2007 were studied. Results indicate 
that difference in ethnic background was substantial as poisoning cases were 
predominantly African Americans (79.9%) between 36-45 years old with a male to female 
ratio of 1.3. Intentional illicit drug overdose was the greatest risk factor for ED poisonings, 
and among the 649 cases, heroin overdose was the most common cause of poisoning at 
35.4% (n=230), cocaine overdose at 31.7% (n=206), heroin and cocaine overdose at 4.3% 
(n=28), multiple drug poisoning at 5.5% (n=36), and antidepressant/antipsychotic 
poisoning at 6% (n=39). A significant correlation between heroin poisonings and asthma 
  
ix 
(F=20.29, DF=1, p= .0001) was found, as well as between cocaine poisoning and 
hypertension (F=33.34, DF=1, p=.0001), and cocaine poisoning and cardiovascular 
diseases (F=35.34, DF=1, p=.0001). Another significant finding is the change in the 
pattern of the route of illicit drug use from injection to inhalation; it is thought this may 
reduce the rate of HIV and Hepatitis transmission via hypodermic needles among illicit 
drug users. As well, inhalation and insufflation may be risk factors that aggravate 
preexisting asthma. Mental illnesses, chiefly depression, remain one of the greatest risk 
factors for suicidal poisoning beside age, Hispanic race, gender, ingestion route and 
unemployment. This study provides supporting evidence that poisoning, particularly 
deliberate poisoning with illicit drugs remains a serious issue that significantly aggravates 
co-morbidities and raises treatment cost by increasing both the rate of hospitalization and 
hospital length of stay (LOS). Pragmatic guidelines and innovations in reducing heroin 
and cocaine abuse in these patients may lessen the severity of diseases and reduce its 
burden on the healthcare system and on society. 
 
  
 
 
 
 
INTRODUCTION 
 
 
Poisonings from intentional substance abuse, as well as from unintentional toxic 
exposures, remain a significant health concern for hospital emergency departments. It is 
estimated that there are more than four million incidents of poisoning in the United States 
each year.  The Institute of Medicine has recently identified that poisonings are the 
second leading cause of injury-related mortality, with an estimated cost of over $12.6 
billion annually (Koplan et al. 1993). 
The majority of poisonings, particularly minor and moderate cases, are commonly 
managed at home with the direction of local poison centers via telephone.  While the 
surveillance of moderate poisonings is well documented in this way, severe cases of 
poisoning that necessitate an emergency department (ED) admission are often not 
reported to poison control centers, and subsequently, the magnitude and trends of severe 
poisonings is unknown, and can only be analyzed using patient data from hospital 
emergency departments. This study is intended to fill these data gaps, to study the 
etiological causes of poisonings and to characterize its demographics and trends.  
The substances responsible for accidental poisoning and the methods used for 
self-poisoning have changed considerably over time (Howton et al. 1997, Townsend et al. 
2001). In many countries, especially in Western Europe and North America over the last 
two decades, the most common agents taken by adults have been illicit drugs (Byard et al. 
2004, Townsend et al. 2001).  
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The annual incidence of intentional and unintentional poisoning in developing 
countries varies from 0.2 to 9.3 cases per 1,000 population, and continue to increase 
annually worldwide (Gulsah & al). The characteristics of poisoning in third world 
countries are slightly different from what is seen in the western world. Agricultural 
chemicals, particularly pesticides, are still on the top of the list for both intentional and 
unintentional poisoning and are still serious public health concerns in these countries.  
In the United States, emergency department (ED) visits for attempted suicide and 
self-inflicted injury are relatively common, serious, and most frequent among adolescents 
and young adults. Self-poisoning is the most common method for suicide. The high 
prevalence of psychiatric and substance abuse disorders suggests there is an association 
between the two. 
Knowledge of condition-specific morbidity and mortality for patients with asthma 
as well as other aggravating factors is essential for making critical decisions. Substantive 
differences have been reported in terms of the prevalence of drug abuse among asthma 
patients; however the etiology and the mechanisms of action for this association have not 
been explained. 
 There is a need, especially for the underserved minority communities that have high 
frequencies for certain methods of drug use, to understand the factors involved in 
poisoning and how to effectively design prevention programs for the purpose of reducing 
their occurrence and adverse outcomes.  
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STUDY AIMS AND OBJECTIVES 
 
The objectives of the study are: To conduct a retrospective chart review to 
characterize the demographics of acute poisoning of patients that visited or were admitted 
to ED (ED poisoning) between December 2004 and May 2007; To identify the most 
common substances associated with poisonings and stratify them by route, age, gender, 
time of the day and reason for admission. Co-morbidities of mental disorders, asthma, 
diabetes, chronic hypertension, cardiovascular diseases, arthritis, cancer, drug abuse and 
occupational exposures will also be examined to assess their correlation with ED treated 
poisoning.  
A cost assessment was also designed to assess the burden of heroin and cocaine 
poisoning on asthma patients. Specifically this study will assess the type and route of 
poisoning and stratify them by illicit drug, pharmaceutical, chemical, occupational, 
industrial or domestic poisonings. This investigation will assess the circumstances of the 
poisoning including accidental or intentional suicidal. The rate of hospitalization and the 
final outcome of poisoning events will be examined. This study will evaluate the rates of 
complications from poisonings as well as the length of stay and the casualty rates if any 
have occurred. On site initial management received by patients at home or administered 
by patients’ families before arrival to ED and its effect on the final outcome of the case 
will be examined in order to estimate which of these factors are most predictive of the 
outcome and poisoning final disposition.  
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 BACKGROUND AND LITERATURE REVIEW 
 
 
 
Poison exposure is a significant health concern and it is the third most common 
cause of death that occurs at home (Schauben & Spillane, 1991). While the overall true 
incidence is unknown, it is estimated by many researchers that there are over four million 
poison exposures per year (Litovitz et al. 1995.) 
According to the Center for Disease Control and Prevention (CDC), cases of 
poisoning are grossly underestimated and a significant number of them never reach the 
hospital since many of the minor case are treated at the patient’s home and are never 
recorded through poison control centers. Among all deaths due to poisoning, carbon 
monoxide intoxication is the most prevalent. 
Over 86 percent of all reported poisoning cases were related to accidental exposure, 
while suicidal or self poisoning accounted for less than 8% of the total reported 
poisonings (Litovitz et al. 1995; Simonsen, 1992). The largest proportion of accidental 
poisonings represented events that were preventable. The “Healthy People 2000” report 
has called for the importance of the reduction, prevention, and treatment of poisoning 
(Litovitz et al. 1994).  
In a study conducted in Barcelona, Spain, it was estimated that poisoning 
constituted 5.2% of all emergencies. Among poisoning cases reviewed in this study 
87.2% were due to heroin related events, 13.1% were due to acute alcohol intoxication 
and 6.2% were due to acute medicinal intoxication.  During the study period of 3 years, 
the authors identified over 233 emergencies involving cocaine. Of these, 55% were 
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female with a mean age of 28.3 years. The authors also reviewed 1,134 patients with 
episodes of acute poisonings seemingly related to pharmaceutical drugs. The most 
commonly used drug was benzodiazepines at 56.7%, followed by analgesics at 12.6% 
and barbiturates at 11.7%. The Barcelona study also identified 1,456 toxicological 
emergencies; 62% of these were suicidal attempts, and 12.6% accidental intoxications. It 
is important to note that in this study the author has included withdrawal syndrome within 
the definition of heroin and cocaine poisoning in his statistics (Monteis Catot et al. 1990). 
Drug abusers are more likely to be hospitalized, and 2.3 times more likely to use an 
emergency room than non-abusers (Stein et al. 1993). Patients using drugs are frequently 
seen in EDs and drugs encountered generally reflect regional and city variation, as drug 
obsession sweeps through subcultures. It is now known that there is a tendency for 
specific drug subcultures to grow locally around the use of specific agents. The overall 
local drug use trends in the United States indicate that cocaine abuse decreased between 
1992 and 2002 (Bernstein et al. 2005). On the other hand cocaine abuse decreased in five 
states by more than 60% it increased 100% or more in four other states. 
A considerable part of emergency care is treating medical complications of 
substance abuse, but the actual abuse of drugs is often not addressed in ED (Bernstein et 
al. 2005). This lack of interest to identify drug abuse may relate to the fact that 
physicians, particularly emergency physicians (EPs), use illicit drugs as often as the 
general population (Hughes et al. 1999). 
Marijuana is the most commonly used drug in the United States, but leads to less 
ED visits than other drugs. Researchers estimated that there were over 2.6 million new 
marijuana users in the year of 2001. Over 3.1 million Americans use marijuana daily, and 
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over 14 million of Americans aged 12 and older use marijuana at least once a month 
(NIDA 2008). In recent years marijuana has become more potent than of what it was in  
the 1970s and 1980s, which resulted in more ED visits among youth, and in 2002, 
marijuana became the third most common drug seen in ED. Marijuana  use increased by 
over than 24% between 2000 and 2002 (Whalen et al. 2006, NIDA 2008) 
Another significant increase seen in recent years is the use of non-crack cocaine 
among tenth graders, which has risen from 1.1% in 2003 to 1.5% in 2004. The same 
study, however, reported that heroin, crack cocaine, hallucinogens, phencyclidine 
amphetamine, tranquilizers, sedatives, and methaqualone use remained stable among 
youth from 2003 to 2004 (NIDA, 2006). Heroin use remains to be a serious problem in 
some regions of the United States. A recent change in the route of use of heroin was 
noted, and there is a new practice of mixing heroin and heating it in aluminum foil then 
inhaling through a straw, or mixing it with cocaine promoting the significant shift from 
heroin injection to heroin inhalation. Heroin abuse is associated with fatal overdose, 
spontaneous abortion, and serious infectious diseases like HIV and hepatitis among IV 
abusers, and rare cases of spongiform leukoencephalopathy. 
Although heroin, cocaine, and marijuana remain the most frequently abused drugs 
leading to ED visits, ED visits involving narcotic analgesics increased 153% from 1995 
to 2002. The use of drug combinations were involved in 75% of the drug abuse–related 
ED visits, and dependence was the underlying factor in these ED visits. In 2003, about 
4% and 4.5% of high school seniors reported nonmedical use of oxycodone. These users 
have a higher economic status. (D'Onofrio Gail et al, 2006). 
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The Substance Abuse and Mental Health Services Administration estimates that in 
2003, 6.3 million Americans abused prescription drugs. Most abused pain relievers (4.7 
million); others abused tranquilizers (1.8 million), stimulants (1.2 million), and sedatives 
(0.3 million). Nonmedical use of oxycodone increased from 11.8 million users in 2002 to 
13.7 million users in 2003. (Volkow, NIDA 2004/2005). 
A shift to smoking has occurred for the use of stimulants and this route has 
increased from 12% in 1992 to over 50% in 2002. In 2003, an estimated 378 thousand 
drug users met the diagnostic criteria for stimulant dependence in the United States 
(NIDA, 2006). 
Cocaine is a strong central nervous system stimulant. It can result in acute 
myocardial infarction or stroke and sudden death. Cardiac complications, such as cardiac 
arrest and seizures are generally the main causes of cocaine-related deaths. The use of 
cocaine occurs in a binge pattern, during which the drug is repeatedly taken at high doses. 
If cocaine is mixed with alcohol, the product is cocaethylene intensifies cocaine’s 
euphoric effects, but also increases the risk of sudden death. The wanted effect of cocaine 
is usually the resulting euphoria that lasts 15 to 20 minutes if snorted and 5 to 10 minutes 
when smoked. In addition to euphoria, cocaine can raise blood pressure, cause 
tachycardia, constrict vessels, and dilate pupils.  
The wanted effect of heroin users is euphoria, (also called “rush”); heroin can also 
cause flushing of the skin, and dry mouth. When tolerance develops, heroin users become 
obliged to use higher doses in order to achieve the same wanted effect.  
 Opioid overdose causes respiratory depression that can be reversed by Naloxone. 
The onset, severity, and duration of withdrawal symptoms depend on the opioid abused 
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and the extent of dependence. Sixty-two percent of primary heroin admissions reported 
injection as the route of administration, 33% reported inhalation, and 3% reported 
smoking. Maintenance treatment for heroin addicts involves daily oral synthetic opiate 
administration usually methadone. Buprenorphine is also a medication now available for 
treating addiction to opiates.  
Treatment of teenagers for marijuana dependence and abuse has increased 142% 
since 1992. Marijuana is known as a recreational drug, particularly to teens. Teenagers 
are three times more likely to be treated for marijuana than for alcohol and six times more 
likely to be in treatment for marijuana than for all other drugs combined (Stephens et al. 
2000).  
The proportion of admissions for abuse of stimulants increased from 1% to 7% 
between 1992 and 2002. Abuse of prescription medications has increased in all segments 
of the population. In 2003, about 4% to 4.5% of high school seniors reported nonmedical 
use of oxycodone (NIDA, 2006). 
“Club drugs” are sometimes preferred over other types of drugs like marijuana and 
heroin or methamphetamine because some users see them as social interaction enhancers. 
Club drugs such as GHB, flunitrazepam or ketamine are taken in combination, or with 
alcohol. They are easy to acquire and they are generally favored over marijuana, lysergic 
acid diethylamide, methamphetamine, and opiates (Gahlinger, 2004).  
Hallucinogens are less commonly used. Most users of lysergic acid diethylamide 
voluntarily decrease or stop its use over time. Lysergic acid diethylamide is not 
considered addictive (NIDA, 2006).  
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Gulsah et al. 2005 reviewed the frequency and mortality risk factors of acute adult 
poisoning in Adana, Turkey from 1997 to 2002 and included 2,229 adult patients. The 
authors reported that 1.6% of their emergency cases were poisoned and the majority of 
these poisoned cases were attempted suicides (76.4%). Drugs were the most common 
(59.0%) poison used, and pesticides were the second (26.4%) most common substance 
encountered. Among drugs, psychoactive were the most common (35.5 %). 
The number of drug abusers is increasing across the U.S. at an alarming rate, 
though many of the related deaths are preventable. According to a recent report 
conducted in Multnomah County, Oregon, heroin alone was implicated in over 3805 
deaths between 1993 and 1999 (Koplan et al., 2000).  
Heroin has greatly increased in popularity in recent years. For many young people, 
it is now the drug of choice, with a dose or "hit" available on some streets for the same 
price as a pint of beer.  
The low price indicates there is a significant supply of the drug.  Low and middle 
class youth seem to be particularly lured by the drug; and the most prevalent route of 
administration has also shifted since the early 1990s to sniffing and snorting over 
injecting the drug. The drug has been widely available, and heroin on the street now is of 
a higher purity and better quality than before. 
The association of drug abuse co-morbidity, particularly cocaine and asthma, has 
been reported in few articles. A study conducted in Bronx, NY, where the author studied 
the occurrence of new onset bronchospasm or recrudescence of asthma, established a 
correlation between cocaine use and new onset asthma. (Osborn & Al. 1997).  
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The evidence of heroin’s effect on the respiratory system, particularly the lungs, has 
been studied by Steensen et al in 1993 who established a direct relationship between 
heroin abuse and pulmonary edema. This research did not clearly describe the mechanism 
of action but it was concluded that one possibility is the increased pulmonary 
permeability of the lung capillaries in response to the exposure. In 2004 Marby et al 
found a pattern of heroin overdose-induced pulmonary edema.  
In the early twenty first century, cocaine and heroin abuse was studied, and were 
found to increase the rate of intubations and hospital utilization in patients with acute 
asthma exacerbation (Levine et al. 2005). 
When heroin was first discovered to be correlated to patients with life threatening 
asthma in the early 1990s from a limited set of cases, it was initially thought that this was 
a novel phenomenon that did not exist before, and was related to the change in the pattern 
of the drug exposure from injection to inhalation (Krantz et al, 2003). For the purpose of 
verifying if this is a new phenomenon, a limited retrospective study was conducted which 
concluded that this relationship has existed prior to the 1990s. 
      In reviewing the literature however, it was found that this model of correlation was 
also described in 1988 when an unexplained exacerbation of asthma in 3 cases that 
required intubations was linked to heroin use (Hughes  et al.).  
 Heroin insufflation was then studied by Krantz at al. 2002 to further investigate 
this theory and attempted to demonstrate that the insufflation of heroin functioned as a 
trigger for patients with life threatening asthma. In this study, the authors reported that of 
the total 104 patients admitted to ICU, most patients were not significantly different in 
mean age or sex between groups of patients with diabetic ketoacidosis (DKA) and 
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asthma. Although the racial distribution did differ in that the DKA group had more 
Hispanics than whites in the asthma group. However compared to ICU admissions with 
DKA, asthmatic patients reported higher prevalence of heroin use (41.3% vs. 12.5%). 
Asthmatics were also more likely to report cocaine use, but the difference between the 
two groups was not significant. 
Levine et  al. identified 152 ICU patients of which he found 27.6% used cocaine 
without heroin (and they were classified as cocaine users) and 30.9 % used heroin with or 
without cocaine (and were classified heroin users). Cocaine users had longer lengths of 
stay than non-users (3.4 vs, 2.5 days p<0.049) and were more frequently hospitalized and 
intubated. Heroin users were intubated more frequently than non-users. Neither hospital 
stay nor percentage of ICU admissions was significant (Levine et al. 2005). The author 
showed that both cocaine and heroin might have induced asthma exacerbation by 
multiple effects on the bronchus, such as the morphine bronchoconstrictive effect (a 
metabolite of heroin through deregulation of mast cells and subsequent release of 
inflammatory mediators particularly histamine) (Withington et al. 1993). 
In a case series reported in late 2005, Cygan et al. described 5 cases of status 
asthmatics that were induced by heroin inhalation. Though he hypothesized that the cases 
were directly triggered by the inhalation of the drug, the author was unable to establish a 
single mechanism of how heroin triggered asthma.  
There are several suggestions about the mechanism of action of heroin related 
asthma effects, but pulmonary mast cell degranulation secondary to heroin may be very 
plausible as indicated by an experiment that used intradermal and IV morphine and 
synthetic opiate administration, resulting in a stimulation of mast cells to release 
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histamine. This release of histamine is a direct pharmacologic mechanism independent of 
opiate receptors.  However, none of the studies that suggest heroin acts as a trigger for 
asthma have reported that the exacerbation occurred at the time of the first use.  This 
makes the histamine release theory very unlikely though it seems very appealing. Unless 
the heroin sensitization period is extremely long, which is contrary to what is currently 
known about immunological sensitization. Association of other factors that are receptor 
independent might be also possible. The controversy regarding this issue remains, given 
the fact that opioid receptor action is thought to result in reduction of bronchoconstriction 
by blocking the cholinergic factor in bronchoconstriction.  
Asthma is a multifactorial disease influenced by genetic and environmental factors 
(Matthis et al. 2006). A recent study have revealed the involvement of some receptors 
regulated by inherited genes in the pathogenesis of asthma that could predispose some 
families or ethnic groups to higher risk for acquiring asthma (Lachheb et al. 2008). In the 
past decade, several loci and over 1100 genes have been found to be associated with the 
disease in some populations. Among these loci, region 12q13-24 has been implicated in 
asthma etiology in multiple populations, suggesting that it harbors one or more asthma 
susceptibility genes (Balaci et al. 2007). On the other hand there are significant and 
distinct changes in the profile of gene expression in the human nucleus associated with 
cocaine and heroin abuse (Albertson et al. 2006) and several gene variants have been also 
detected and inferred to contribute to heroin abuse and addiction. For most of these 
genes, however, the relationship to the pathophysiology of asthma remains speculative, 
and none appear to be directly involved in the activation of airway inflammatory 
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processes or allergies, or explain fully all the aspects of the complex mechanism of 
addiction and abuse of heroin. 
Several studies suggest the presence of a relationship between mental illnesses and 
poisoning for self-harm. Attempted suicide is known to be risk factor for committed 
suicide, and certain characteristics were seen among those who commit suicides such as 
having made previous suicide attempts, or having a family member who has attempted 
suicide. One of the studies has shown that attempted suicide is most closely related to 
depression. But the study concluded that patients with depression were significantly more 
often aged, male, married, and used methods other than poisoning by solids or liquids 
compared with patients with other mental disorders (Ichimura et al. 2005). 
Depression is the disease most often implicated in suicide. In many countries, there 
has been a consistent increase in suicides among adolescents and young adults, as well as 
a decrease in suicides among women. The management of depression includes 
antidepressant medication. However, appropriate antidepressant prescribing is a very 
important factor in terms of preventing fatal antidepressant overdose. The actual risk of 
suicide in patients prescribed an antidepressant may be up to 10 times greater than for 
others. The likelihood for serious and potentially fatal poisoning following overdose 
differs considerably among the drugs available. Most deaths from overdose are 
attributable to tricyclic antidepressants (Henry 1996). 
Howton, in a meta-analysis focused on patients with bipolar disorder in which 
suicide (13 studies) or attempted suicide (23 studies) was reported as an outcome. The 
study identified the main risk factors for suicide as previous suicide attempt and 
hopelessness. The main risk factors for nonfatal suicidal behavior included family history 
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of suicide, early onset of bipolar disorder, extent of depressive symptoms, increasing 
severity of affective episodes, the presence of mixed affective states, rapid cycling, co-
morbid Axis I disorders, and abuse of alcohol or drugs. The author concluded that in 
patients with bipolar disorders, prevention should include attention to these risk factors in 
assessment and treatment, including when deciding whether to initiate treatment aimed 
specifically at reducing suicide risk (Hawton, et al. 2005). 
According to Nordentoft et al. 2007, who focused their work on the prevention of 
suicide in Denmark, where suicide rates have been declining in the last two decades for 
all age groups, the decline seems to be largest among females. Their conclusion is that 
the decline is mainly due to the focus on psychiatric patients, especially schizophrenic 
related disorders and homeless persons. In his study he identified that the most significant 
risk factors for suicide are: male gender, young age, short duration of illness, multiple 
admissions during the prior year, shorter time since discharge from a healthcare facility, 
co-morbid depression, drug abuse, poor compliance with medication and high IQ 
(Nordentoft et al. 2007).   
Another study conducted in Mexico in 1999 concluded that there were high rates of 
suicide related depressive disorders in a predominantly female population. Drug products, 
according to the author, were more frequently used than home or work related chemicals. 
The mortality related to poison exposure was very high at 27% and 16% with permanent 
squeal, though advanced life support and antidote medications were available (Kingsbury 
et al. 1999). 
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STUDY HYPOTHESES 
 
1- Drug abuse overdose is the greatest risk factor for ED poisoning compared to 
the other environmental, occupational or prescription medication drugs. 
2- There is a correlation between preexisting history of chronic disease, such as 
asthma and intentional poisoning using heroin or cocaine. 
3- Mental illness, such as depression and psychotic disorders, are risk factors for 
ED poisoning. 
4- Illicit drug poisoning is a burden on asthma patients, and it incurs longer 
hospital stays and higher hospital costs compared to those who do not present 
with a history of illicit drug poisoning. 
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 METHODS AND MATERIAL 
 
 
1.0- DESIGN OF THE STUDY 
 The study population consists of Chicago city residents visiting the Emergency 
Department (ED) of the Sinai Hospital between December 2004 and May 2007. The 
Sinai System provides virtually all-medical and surgical care in the area and it also 
includes a children’s hospital and a rehabilitation center. The hospital is serves the 
population 5 miles west of down town. This population is diversified between African 
American, Hispanic, white, and Indian ethnicities.  
This study is retrospective, and all cases of poisonings were identified through a 
search of the electronic records using the International Classification of Disease Ninth 
Revision, Clinical Modification (ICD-9-CM). A database of all ED poisoning cases was 
compiled from ED electronic records. Data pertaining to history of chronic disease co-
morbidities, as well as to poisoning by illicit drugs, pharmaceutical, and chemical agents 
was collected. 
The poisoning exposure variable described the type of poison, the poisoning 
exposure route, and the circumstances of intoxications; (intentional, unintentional or self-
poisoning or attempted suicide). Initial management of the event was also collected to 
determine its adequacy and to correlate it to the final outcome and final disposition of the 
poisoning cases. 
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Data on the history of prior poisoning was collected in addition to smoking, 
alcohol, and illicit drug use. The data collection preprinted sheet included also personal 
history of mental illness such as depression, psychosis and anxiety disorders. 
Data on the initial management received and follow-up, as well as the outcome of the 
event as assessed by the treating physician at the time of transfer or discharge was 
collected. 
In order to assess hospital cost and the burden of drug abuse on asthma, a follow up 
study was designed to collect cost data and assess expenses, including expenses paid by 
insurance and by self-payers. Two groups of patients were selected: the first group of 137 
patients was selected from the 649 patients initially compiled for poisoning. The second 
group was randomly selected from the pool of asthmatics that were not known to have 
any abuse history or hospitalization for any drug related event. Age, race, and insurance 
coverage data was collected as well as hospital charges, and amounts collected, expenses, 
and length of stay for those hospitalized.   
2.0. DATA COLLECTION & MATERIAL STUDIED 
The data collection was performed according to HIPAA regulations and after 
approval by the hospital’s Institutional Review Board (IRB) committee. The system 
database was queried for cases of poisoning during the period between December 2004 
and May 2007 to generate a list of patients to be enrolled into the study.  
Data abstracted from patients’ medical records included age, gender, race, date and 
time of the visit, marital status, employment, insurance coverage, chief complaint and 
vitals on admission. Information on the patient’s personal medical history of diabetes, 
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mellitus, hypertension, cardio-vascular diseases, asthma, arthritis, HIV, hepatitis and 
seizure disorders was recorded. 
Initial medical management and assessment of the gravity of the case was 
recorded and then weighed against the final outcome in order to discern the cases that 
were not considered serious, but resulted in an adverse outcome; this may help ED 
determine areas to implement preventive measures in order to avoid any possible 
underassessment of patients at risk. Any discrepancy in time of initiation of the treatment 
after patient arrival was recorded and delays will be compared and correlated to the final 
outcome of the patient. This includes the cases that were managed in a non–health care 
facility or at the site of exposure. The percentages of patients initially treated and referred 
from another health care facility have also been evaluated. 
Treatments, such as the use of antidotes, were recorded to assess the availability 
of necessary treatment as well as any deviation from the recommended standards. The 
management provided was then classified in the following categories: Decontamination 
only, Observation only, No therapy provided, Decontamination and other therapy, 
“other” therapy only (without decontamination). Patients’ health coverage, 
unemployment, and history of mental illness such as depression, psychotic disorders, or 
personality disorders were analyzed. Significance of mental illness in the group of 
patients who repeatedly attempted drug or chemical intentional self poisoning has been 
explored and the correlation of addiction history with mental illness co-morbidity has 
been examined.  
Voluntary vs. unintentional, domestic chemical use vs. agricultural and industrial, 
occupational vs. environmental, pharmaceutical intentional vs. pharmaceutical adverse 
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reaction illicit drug use, and recreational intoxication have been stratified by age, sex, 
socio- economic status, employment, presence of history of chronic illness, alcohol use 
and mental illness have been examined for correlation with the final outcome of the 
poisoning cases.  
Although morbidity and mortality of acute poisoning are increased in elderly 
compared to younger patients, little has been published on this issue. To investigate the 
influence of age on the clinical course of acute poisoning, the cause of acute poisoning 
and the clinical outcome have been recorded. As compared with younger patients, mean 
length of stay at the ICU, if found to be significantly higher this might indicate a more 
serious course of acute poisoning.  
3.0. DEFINITION OF VARIABLES 
Poisoning was defined as a condition or physical state produced by the ingestion, 
injection or inhalation of, or exposure to a deleterious agent. Poison exposure may 
include any medicinal drug, environmental, agricultural, industrial, or occupational 
substance that may or may not result in a visit to the Emergency Department (ED).  
Environmental poisoning is any passive, non-occupational exposure that results from 
contamination of air, water, or soil.  
Occupational exposure is an exposure that occurs as a direct result of the workplace. 
Therapeutic error is an unintentional deviation from a proper therapeutic regimen that 
results in the wrong dose, incorrect route of administration, administration to the wrong 
person, or administration of the wrong substance.  
Drug interactions resulting from unintentional administration of drugs or foods which are 
known to interact are also included.  
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Unintentional misuse differs from intentional misuse in that the exposure was unplanned 
or not foreseen by the patient. 
Bite/sting includes all animal bites with or without stings. 
Food poisoning is a suspected or confirmed ingestion of food contaminated with 
microorganisms. 
Suicidal poisoning is a poisoning that results from an inappropriate use of a substance for 
reasons that are suspected to be self-destructive. 
Intentional misuse is defined as an exposure resulting from the intentional improper or 
incorrect use of a substance for reasons other than the pursuit of a psychotropic or 
euphoric effect. 
Unintentional poisoning is all unintentional exposures not otherwise defined. 
Intentional abuse is defined as an exposure resulting from the intentional improper or 
incorrect use of a substance where the victim was likely attempting to achieve a euphoric 
or psychotropic effect. All recreational use of substances for any effect is included. 
The category malicious poisoning is used to capture patients who are victims of another 
person’s intent to harm them. 
Minor effect is a situation where the patient developed some signs or symptoms as a 
result of the exposure, but they were minimally bothersome and resolved rapidly with no 
residual disability or disfigurement.  
Moderate effect occur when patient exhibits signs or symptoms as a result of the exposure 
that were more pronounced, more prolonged, or more systemic in nature than minor 
symptoms. Some form of treatment is indicated but Symptoms were not life threatening, 
and the patient had no residual disability or disfigurement  
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Major effect is defined as when patient exhibits signs or symptoms as a result of the 
exposure that was life-threatening or resulted in a hospitalization or in ICU with or 
without significant residual disability or disfigurement 
Death occurs when patient dies as a result of the exposure or as a direct complication of 
the exposure. 
4.0. DATA ANALYSIS 
Data collected was reviewed and checked for completeness before being entered 
into a database and missing values were excluded using a pairwise deletion. The data was 
then analyzed using SPSS 16.0 statistical package.  Continuous variables such as age, 
duration of hospital stay, and duration of time between poisoning and hospital arrival was 
analyzed using student’s t test or one-way analysis of variance (ANOVA) between 
groups. The categorical data between groups was analyzed by using the Chi square test; 
Odds Ratio, and confidence interval, (CI) was calculated by a full factorial univariate 
analyses and stepwise multiple logistic regression analysis. Correlation analysis was 
conducted using the Pearson r correlation coefficient. Results obtained will be presented 
as mean ± SD and percent (%). A p value of less than 0.05 will be considered significant 
for the various association between variables specifically association between asthma and 
exposure, between exposure and outcome, final disposition, suicidal poisoning and 
chronic diseases such as depression psychosis 
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RESULTS 
 
 Between December 2004 and May 2007 a total of 649 patients’ encounters were 
identified. The poisoning diagnosis was made based on a documented acknowledgement 
by the patient for taking the drug or by a positive urine drug screen that is done 
systematically for any suspected specific exposure. The first section will present the 
demographics of the exposure, the second section will explore poisoning agents of 
exposure, the third will describe co-morbidities, the fourth section will describe the 
correlations between variables, and the fifth section will describe predictors.  
1.0. DEMOGRAPHIC CHARACTERIZATION 
1.1- Age and Gender 
The distribution of age and gender is shown in Table 1 and Figure 1; age varied 
between 1 and 89 years with a median of 39.7 years and a standard deviation of 13.6.  
 
FIGURE 1: Age distribution: cases were predominantly adult between 36 and 45 years 
old. Pediatric cases younger than 15 years old represented only 4.6%. 
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In the pediatric population 4.6 % were younger than 15 years old and, as shown in 
Figure 1, the most frequently affected age was 48 years old and the most commonly 
affected age group was between 36 and 45 years old. The middle aged adult population 
for both sexes represented 35.7% of the total cases. The younger adult group of 16 to 35 
years old represented only 10.6% and ranked third after the 46-55 years old that scored 
22.7%. Of the total of 649 poisoning cases there were more male, than female, with 
42.7% (n=277) females and 55.9% (n=363) male to female ratio of 1.3.  
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: Poisoning distribution by gender: more male, than females were seen with 
male to female ratio of 1.3. 
 
Below (Figure 3) is a side-to-side (or a mirror effect) graph of the male to female 
frequency on an age range. This population pyramid allows a better comparison of the 
various gender differences by age brackets. The distributions of gender by age seem 
globally similar, but clearly the peaks look different where females are more common at 
ages 40 to 43 as compared to males that peak at 46 to 49 years old. Among children it 
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seems there were more poisoning cases among male infants at very early age (2-3 years) 
than females.  
 
 
 
 
 
 
 
 
FIGURE 3: Population Pyramid: distribution of poisoning cases by gender and by age. 
Poisoning population peaks at 49 years old in male s and at 40 to 43 in females.   
1.2- Race and Marital Status 
 
The difference in ethnic background was substantial as the poisoning cases were 
predominantly African Americans (79.9%).  
 
 
 
 
 
 
 
 
 
FIGURE 4: Poisoning distribution by race and age: The poisoning population race is 
predominantly African American then Hispanics and Whites in third position. (Race_AA: African 
American, Race_Hisp: Hispanic) 
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Hispanics were the second most prevalent with 11.9%, followed by Whites at 
6.6%. Over 69.3% (n=450) of the total cases were single in comparison to only 12.3% 
(n=80) were married. Results of the married and unmarried patients by age are displayed 
in Figure 5. 
 
 
FIGURE 5: Marital Status. Distribution of married versus unmarried patients shows a 
predominantly single population as compared to only less than 20% married (Marit_Single: 
Marital status single; Marit_Marr: Married)   
 
There were more singles cases than married cases and singles cases were 
predominantly aged between 37 and 49 years old. 
1.3- Employment and Insurance Coverage 
 
              Most patients were self-covered 45.8% (n=297), 35.1% (n=228) of the cases 
were covered by the Illinois Department of Public Aid (IDPA). Only 5.9% (n=38) 
patients had private coverage. Medicare and Medicaid covered only 8.2% of the total 
cases.  
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FIGURE 6:  Poisoning by employment status. Most poisoning cases were unemployed 
and not covered by any insurance, shown in Figure 6 and Figure 7. 
 
Most patient with poisoning episodes brought to the hospital were unemployed 
87.4% (n= 567) as opposed to only 9.4% (n=62) of employed. 
 
 
 
 
 
 
 
 
 
FIGURE 7: Population pyramid, Employment distribution by age. The age group that is the 
mostly affected was between 37 and 52 years old.  
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1.4- Mode of Arrival  
 
Fifty three percent (n=345) of patients with poisoning were brought by the 
Chicago fire department in response to a 911 call from a patient’s families, or from the 
police department.  Twenty nine point six percent of patients (n=192) walked in the 
emergency department or were brought by a family member or in a wheelchair. Only 
0.5% of the case visited their primary care physician (PCP) before presenting to the 
emergency department. 
 
 FIGURE 8: Mode of arrival of patients with poisoning to ED. Chicago Fire Department 
brought more than half of the total cases.   
 
  The Pearson correlation test showed that there was a significant correlation 
between mode of arrival and age (r=-.119, DF=589, p=.004), marital status (r=.113, 
p=.006 and DF=627), pulse (r=-.111, DF=622, p=.007), exposure (r==.134, DF=591, 
p=.001) and also with the final disposition (r=.111, DF=582, p=.007).  Though these 
correlations are not strong, it could reflect that the predominance of heroin and cocaine 
cases mostly brought by police and fire department resulted in more hospitalizations 
compared to the other patients that just walked in or were brought by other means. Also, 
these correlations could be related to the fact that the outcome is generally worse when 
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EMS brings patients given that EMS is generally called only for situations that seemed 
severe or had potential for complications.  
  Arrival mode was also significantly correlated with the final disposition 
particularly to hospital admission (p=0.04). No correlation was established between death 
and the way the patient arrived to ED. 
1.5- Chief Complaint Analysis 
 
Given the wide variation of the diverse symptoms related to poisoning, the chief 
complaint was classified in seven categories that were estimated to be the most common.   
Category one includes unresponsiveness, Loss of consciousness and or Coma and it 
included 22% (n=143) of the total patients.  
  Category two includes cardio vascular complaints such as chest pain, angina, and 
or coronary artery disease. This category was the most representive in our series and 
more than 25.9% (n=168) of the cases presented with these chief complaints. 
Category three is pulmonary related complaints such as Shortness of breath (SOB), 
cough, wheezing or exacerbation of a preexisting asthma. In our series, 22.2% (n= 144) 
of patients presented with this latter complaint. Category four is drug overdose related 
symptoms, this category involved 15.4 % (n= 100) of our patients.  
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FIGURE 9: Chief complaint at the level of ED triage. Most patients presented for chest 
pain or were brought by CFD unresponsive or with shortness of breath. 
 
1.6- Vitals on Admission 
               1.6.1- Temperature on Admission  
 
 
 
FIGURE 10: Admission temperature ranged between 86.0 and 105.0 with a median of 
98.0 degree Frenheight.  
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                 1.6.2- Heart Rates 
  As shown below in Figure 12, only 2.6% presented with a bradycardia less than 
50 and 56.4% (n=366) presented with pulse between 50 and 100 and 39.4% (n=249) with 
pulse over 100. 
 
 
 
FIGURE 11: Pulse at arrival to ED. over 35 % of patient had a tachycardia that was 
higher than 100beat per min. 
 
           1.6.3- Respiratory Rate  
 
FIGURE 12: Respiratory rate on admission. RR was normally distributed that peaks in 
the high 20s 
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1.6.4- Blood Pressure Systolic 
 
 
FIGURE 13: Frequency and percent systolic blood pressure on arrival to ED. Over 30% 
of patients presented with systolic high BP over 140 and 10% presented with a systolic 
BP over 200mm/hg.  
1.6.5- Blood Pressure Diastolic 
  Diastolic blood pressure was not significantly correlated with either heroin or 
cocaine use, but it was correlated to alcohol use (p= 0.015) analgesics (p= 0.24) and to 
marijuana use (p=. 006). 
 
 
FIGURE 14: Frequency and Percent of diastolic Blood Pressure on arrival to ED 
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1.6.6- Glasgow Scores 
Glasgow coma scale, known as Glasgow score; a reliable tool for assessing 
consciousness was significantly correlated to heroin (p=0.002) and to cocaine overdose 
(p=0.002) 
2.0. POISONING AGENTS 
  Poisoning exposure was grouped into fifteen toxic substances or drugs and in four 
different categories: pharmaceutical or medicinal drugs, recreational drugs, chemicals or 
chemical industrial. Circumstances of the exposure were also captured and categorized 
into seven intent groups that included: suicidal, abuse, intentional, misuse, unintentional 
and therapeutic and adverse drug events (ADE); the route of exposure was recorded as: 
inhalation, ingestion, and injection, dermatological, vaginal and or rectal. 
 
 
FIGURE 15: ED poison exposure. The poisoning exposure most commonly encount
was heroin followed by cocaine and anti- depressant and antipsychotic medications. 
Multiple drugs inta
ered 
kes were the fourth most commonly seen poisoning exposure in this 
study population.  
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a, multiple drugs, unknown pills, cardio vascular drugs, anti-cold drugs and 
others
 
ons 
gestion in 
te of exposure was 
the most commonly seen route particularly for cocaine and heroin. 
 
  The fifteen exposure substances identified and most commonly encountered in 
ED included heroin, cocaine, alcohol, heroin concomitantly with cocaine, multiple dru
ASA (aspirin), anti-depressors and antipsychotics, stimulants, analgesics, methadone,
marijuan
. 
  In summary agents of poisonings encountered was as follow: heroin represented
35.4% (n=230), cocaine 31.7% (n=206), heroin and cocaine concomitantly taken 4.3% 
(n=28), alcohol 2.2% (n=14), multiple drugs 5.5% (n=36), anti depressant antipsychotic 
6% (n=39), ASA 3.4% (n=22), cardio vascular drugs 2% (n=13), anti-cold medicati
1.1% (n=2.2), methadone .6% (n=4), CNS stimulants .8% (n=5), Analgesics 1.5% 
(n=10), Marijuana .5% (n=3), unknown pills 1.7  (n=11), other substances 2.9% (n=19). 
The route of the poisoning exposure included inhalation 61.5% (n=400), in
21.1% (n=137), rectal vaginal 10.6(n=69) and injection at 5.2% (n=34.).  
FIGURE 16: Overall route of poisoning exposure. Inhalation as rou
 
  
The exposure circumstances included: abuse 76% (n=498), suicidal 13.4% 
(n=87), misuse 2.2% (n=14), unintentional 3.2% (n=21), therapeutic 2.5% (n=16) and 
ADE .6% (n=4). 
2.1- Poisoning and Medical History  
 
  There was a significant relationship between asthma and the exposure to heroin 
(F=20.4, DF=1, p=0.0001) as well as between history of cardio vascular disease and 
exposure to cocaine (F=35.34, DF=1, p=0.0001). Another significant relationship was 
revealed between the use of cocaine and history of preexisting hypertension (F=33.34, 
DF=1, p=0.0001).  Depression and Psychosis were significantly associated with the 
overall poisoning exposure variable with (F=42.59, DF=1, p= .0001) and (F=6.96, DF=1, 
p=.0001) respectively. 
2.2- Relationship of Poisoning to Smoking and Alcoholism 
 A set of significant relationships were established between poisoning exposure 
and the history of smoking (F=2.90, DF=14, p=0.0001). Another significant relationship 
(F=3.76, DF=14, p=0.0001) was established between the history of alcohol drinking and 
the exposure to poison. History of recreational drug use was also found significantly 
related (F=33.64, DF=14, p=0.0001) to the overall exposure variable.  
3.0. POISONING CO-MORBIDITY 
3.1. Personal Medical History of Diabetes mellitus 
There were over 93 diabetic cases that visited the emergency department for 
poisoning during the study period and they represented 14.3 %. Twelve cases were 
accounted unknown as the history of prior diagnosis was not clear from the patients’ 
records. 
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FIGURE 17: Personal medical history of diabetes and hypertension by age. The 
distribution of the cases of diabetes looks uniformly distributed and it reflected the 
distribution of the poisoning exposure within the total population (on the Y access Sum 
refers to frequency). 
 
  The diabetic patients’ ages ranged between 1 and 89 years with a mean of 46.5 
and a standard deviation of 11.96, similar to the overall age distribution of the population 
studied. More than 59.1% (n=55) were male, 44.1% (n=41) used exclusively cocaine and 
29% (n=27) used exclusively heroin, 2.2% used a combination of both heroin and 
cocaine, and 6.5% (n=6) combined multiple drugs.  
  Among poisoned diabetics patients there were 59.1% (n=55) who also had an 
associated hypertension and 35.5% (n=33) with cardio vascular diseases and 48.4% 
(n=45) of asthmatics. Depression was prevalent among diabetics with 21.5% (n=20), no 
correlation with the overall poisoning exposure variable was established.  
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3.2- Personal Medical History of Hypertension 
 
  Over 31% (n=199) cases were diagnosed with prior history of hypertension. 
Among these there were 27.1% (n=54) who used heroin and 47.2% (n=94), who used 
cocaine, 4% (n=8) who combined both heroin and cocaine, and 5.5% (n=11) who used 
anti-depressants/ anti-psychotics. Smoking was prevalent at 72.4% (n=144) of the 
hypertension group, 60.3 %( n=199) were alcoholics and over 85.4% (n=170) had history 
of drug abuse. Sixty point eight percent (n=121) reported had taken other prescription 
medications the day of their poisoning. Over 71.9% (n=143) of the hypertension patient 
were hospitalized as opposed to only 26% who were discharged form ED; .5% (n=1) 
died, 58.3% had major effect, and 38.7% were categorized in minor events. 
 
 
FIGURE 18: Prevalence of chronic hypertension compared to cardio-vascular co-
morbidity with poisoning. Hypertension (HTN2) and cardio vascular disease (CVD2) 
were similarly distributed in all age groups.  
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  Hypertension was not correlated to the overall poisoning exposure, however it 
was correlated to cocaine exposure (p= .0001). No age difference was seen that could 
explain this significance level.  
3.3.     Personal Medical History of Cardio-vascular Diseases 
 
The number of patient that presented to emergency department with a preexisting 
history of cardio vascular diseases (CVD) represented 17.4 % (n=113). Cardiovascular 
disease included all heart problems and a Pearson correlation test indicated heart disease 
was significantly correlated to cocaine abuse (r=.227, DF=645, p= .0001). 
3.4.     Personal Medical History of Arthritis 
  Personal medical history of arthritis was only seen in 3.5% of the cases (n=23) 
and no significant correlation with any other variable was established, including the 
exposure to heroin that has been previously indicated to cause a degree of arthritis.  
3.5.    Personal Medical History of Malignancy 
Malignancy was rarely seen among cases of poisoning of our study; only 7 
patients presented for poisoning among the 649 cases identified, and no correlation 
between history of cancer and drug abuse or suicidal attempts were found. Contrary to 
the initial hypothesis, that patients with cancer might be at higher risk for poisoning 
because of multiple toxic chemotherapies, as well as their depressive mental state, that 
make them more susceptible for attempting suicide.  
3.6.   Personal Medical History of Asthma 
Asthma was of special interest to this study and it was investigated for possible 
correlation with multiple other variables, we identified the following findings: 
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FIGURE 19: Smoking & regular drinking habits in Asthma, Depression & Psychosis  
 
  Over 41.4 % of our study population had a history of confirmed diagnosis of 
asthma (n=269). Among the 269 asthmatics, there were 45.4% (n=122) who presented to 
ED for a complication related to heroin intake during the last 24 hours before admission. 
Cocaine related visits among asthmatics represented 30.5% (n=82), and alcohol 
poisoning accounted for 2.6% (n=7) of all asthma cases. Concomitant use of heroin and 
cocaine represented 5.2% (n=14), and multiple drugs intoxication was seen in 4.5% 
(n=12) of cases. Marijuana seems to be rare as a cause for emergency visit among 
asthmatics and our population rate was recorded at only 1.1% (n=3.) 
  Asthma patients who visited ED for a poisoning event had almost equal 
distribution of gender; 50.9% (n=135) were female, 49.1% were male. Over 72% (n=195) 
were single as opposed to 11.9% married (n=32). Asthma cases were predominantly 
African American 85.9% (n=231) with 3.3% Hispanic (n=9) and 3.7% (n=10) of white 
descent. Sixteen percent of our asthmatic population were also diabetics, 31.6% (n=85) 
had hypertension, 14.5% (n=39) reported cardio-vascular problems, 3.7% of them had 
been diagnosed with an arthritis, and 2.6(n=7) had a past or current malignancy. 
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Depression co-morbidity among asthma patient was recorded at 18.2% and 8.6% 
(n=23) were diagnosed and treated for a psychotic disorder. Most asthma patients had a 
history of recreational drug use 86.1% (n=229), 24 cases (9%) were seen in the 
emergency department for a self poisoning.  Therapeutic adverse events were also 
reported among asthma patients at a rate of 2.2% (n=6) and misuse of drugs at a rate of 
1.1% (n=2). 
 History of prior poisoning and ED visit or hospitalization for similar events was 
prevalent. In fact over 54.3% (n=146) of asthmatics were documented with prior 
incidents of poisoning that needed a trip to ED at least once. Inhalation was the most 
commonly reported mode of exposure of asthmatics 75.5% (n=203), ingestion was seen 
in 11.5% (n=31), then injection 6.3% (n=17), rectal or vaginal at 4.5% (n=12), and 
dermatological 1.1% (n=3.) Smoking was prevalent among asthmatics at 65.1% (n=175) 
and regular alcohol intake was associated with asthma in 54.6% (n=147). Only 25% 
(n=68) of asthma patients had received initial management on the site of the poisoning 
exposure or immediately at arrival to the emergency department and 11.5% (n=31) were 
given immediate antidote administration. 
From the total 269 patients only 14.5% (n=39) were discharged and 71.7% 
(n=193) were admitted to the hospital or to the ICU for further management. According 
to the ER physician, the assessment of the outcome reported that the poisoning events 
were major in 55.8% where the patient needed extra measures in order to treat their 
poisoning exposures, necessitating sometimes ICU hospitalization, intubation or 
admission to the hospital. 
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The records showed that 84% had had a follow up at the outpatient clinic or were 
referred to their primary care physician. At the time of the exposure, 67.7% of asthma 
patients reported that they were taking their asthma routine maintenance medication and 
53.2% of the total asthma groups were under albuterol treatment. 
A significant relationship between the exposure to heroin and history of Asthma 
was established (p=0.0001). Asthma was not correlated to any of the other substances of 
exposure including cocaine, alcohol, or concomitant use of heroin and cocaine. ANOVA 
test resulted in a statistically significant relationship between asthma and depression (p= 
.044) and to psychosis (.028), however smoking was not significantly associated with 
asthma (p= .066). 
TABLE-1: Summary Table for Diabetes, Asthma and hypertension; demographics 
and agents responsible for poisonings. 
 Diabetes HTN Asthma 
Total study 
population(N) 14.3% (n=93) 31% (n=199) 41.4% (n=269) 
Age 45.9 +/- SD 11.8 47.6 +/- SD 11.3 39.2 +/- 11.9 
Gender M=60.4%, F=39.6% M=66.3%,  F= 33.7% M=49.1%, F= 50.9 
Heroin 29% (n=27) 27.1% (n=54) 45.4 % (n=122) 
Cocaine 44.1% (n=41) 47.2 % (n=94) 30.5% (n=82) 
Smoking 67.7% (n=63) 72.4% (n=144) 65.1 % (n=175) 
Alcohol 53.8% (n=50) 60.3% (n=121) 54.6% (n=147) 
Depression 21.5% (n=20) 17.6 % (n=35) 18.2% (n=49) 
Psychosis 11.8% (n=11) 11.6 % (n=23) 8.6% (n=23) 
Hospitalization 
rates 73.1% (n=68) 71.9 % (n=143) 71.7% (n=193) 
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3.7.     Personal Medical History of Depression 
In our series Depression accounted for 21.6% (n=140) of the total cases and a 
significant relationship was found between poisoning and history of depression. Many 
patients that attempted suicide ingested a higher dose of their own medications for the 
purpose of self-harm. A smaller number presented for adverse drug reaction of anti-
depressor mainly Tricyclics.  Over the 141 cases 27.1% (n=38) visited ED for cocaine 
related poisoning event and 17.1% (n=24) presented for heroin poisoning. The third most 
common poisoning seen in depressed patients presenting to ED was anti-depressants 
15.7% (n=22), multiple drugs 11.4% (n=16), salicylic acid (ASA) 9.3% (n=13), and 
unknown pills .7% (n=1). 
In patients with depressive mood disorders, gender distribution was slightly in 
favor of females with 53.6% (n=75) versus 46.4% (n=65) males with a male female ratio 
of .8 mostly single 70.7% (n=99) versus only 11.4% of married.  African American was 
the major race in this group with 72.9% (n=102); Hispanics were 7.1% (n=10) and 8.6% 
(N=12) were Whites. The majority in the depression group were unemployed at 85.8% 
(n=121), 47.1% covered with IDPA, and 35% were self-payers.  
Over 48.6% (n=68) of the depression group were brought by the EMS and 25.7% 
(n=36) arrived to ED unresponsive and 25% (n=35) of them had a heart related 
complaint, 12.9% (n=18) had a chief complaint that was classified as overdose (OD).  
Suicidal intent was recorded in 42.9% (n=60), and another major circumstance of 
poisoning in the depression group was drug abuse at 52.1% (n=73). Unintentional and 
misuse was only seen in less than .7% (n=1). Medication was the most commonly used in 
this group at 45% (n=63). The main route of poisoning in this study group of documented 
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depression patients was the ingestion route 47.1% (n=66) and the inhalation route 45.7% 
(n=64). Rectal or injection routes were equally recorded at 2.9% (n=4) each. 
Co-morbidity of depression was recorded as follow: Asthma 34% (n=48), 
diabetes 14.3% (n=20) hypertension 25% (n=35) Psychosis 33.6% (n=47) cardio vascular 
diseases 17.9% (n=25) and arthritis 3.5% (n=5). Of the 141 patient 15% (N=21) that 
received immediate management at the site of the poisoning, and 8.5% received 
Naloxone antidote on arrival to the emergency room. Beside antidote and initial 
intervention on the site 20% (n=28) received decontamination only, 35% (N=49) 
received decontamination combined to other appropriate therapy and 36.4% (n=51) 
received other therapy without decontamination.  
Fifty-four percent of the depression group acknowledged smoking tobacco, 55% 
(n=76), regular alcohol intake, 66.7% (n=94) admitted the use of recreational drugs. Over 
half of the intoxication resulted in minor effects, 47.5% had some complication and 
resulted in a major outcome (but not death), and 75.7% (n=106) were admitted to the 
hospital for further evaluation and management. The average length of stay was at 1.4 
days. Of the regular prescription medication noted taken for asthma maintenance 
treatment, albuterol was reported by 14.2% (n=20), anti-depressant medication in 8.5 % 
of patients, anti-hypertensive medication 8.55 (n=12), and clonidine in 1.45 (n=2).  
Of the total cases 11.9% (n=77) were diagnosed and documented with a psychotic 
disorder. Their age varied between 20 and 66 years old, with a mean of 39.32 and a 
standard deviation of 9.55. Patients in this group were predominantly single (79.2%, n= 
61) African American (83.1%, n=64), male (58.4%, n=45) with a male to female ratio of 
1.4. 
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Hispanics represented 3.9% (n=3) of cases and whites represented 9.1% (n=7); only 6.5 
% (n=5) were employed. Insurance coverage was provided by IDPA 51.9% (n=40), 
Medicare 7.8% (n=6), and 27.3% (n=21) were self-payers. 
 
FIGURE 20: Depression and of Psychosis (PSYCH2) by age. The age group the most 
involved is the middle aged between 36 and 45 years old, the same age group affected by 
asthma and diabetes and hypertension. 
 
3.8.     Personal Medical History of Psychosis 
Chicago fire department EMS brought over 56% (n=39) of them to ED and 31.2% 
(n=24) were walk-ins. Over 24.7% (n=19) had a heart related complaint, 13% (n=10) had 
chest complaint like shortness of breath, 5.2% presented for nausea and/or vomiting. 
Overdose as the chief complaint was seen in 13% (n=10) and none of the psychotic 
patients presented for injury following an event of poisoning. 
Among the group of psychotics there were 14.3% of diabetics (n=11), 29.9% 
(n=23) hypertensive, 18.2 %( n=14) with cardio vascular diseases, 29.9% (n=23) 
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asthmatics, 62.3% (n=48) with a diagnosed depression disorder, and (1.3%) with a 
malignancy.  Of the total patients with known psychotic disorders 42.9% (n=33) had 
previously visited ED or were hospitalized for a poisoning related event. 
Over 19.5% (n=15) of the patients with history of psychotic disorders had heroin 
poisoning, 33.8% (n=26) had cocaine poisoning,18.2% (n=18) were poisoned with their 
own prescription medication, and 7.8% (n=6) to multiple drugs combination. Alcohol 
resulted in intoxication in this group only in one case (1.3%). 
In summary, the above poisoning exposures were distributed in 5 categories: 
58.4% (n=45) illicit drug overdoses, 33.8% (n=26) pharmaceutical poisoning (though 
some drugs were also taken for recreational purposes), 7.8% (n=6) chemical industrial 
poisoning. Circumstances of the poisoning were collected from the History and physical 
(H&P) report and were as follow: suicidal 28.6% (n=22), recreational 64.9% (n=50) 
unintentional accidental 2.6% (n=2), and therapeutic error 2.6% (n=2). Concomitant 
medication intake was reported for antidepressant/antipsychotic for 13% (n=10), for 
albuterol in 11.7% of the cases, for anti hypertension medications 9.1% (n=7) of cases 
and clonidine in 2.6% (n=2) of the cases. 
The route of exposure was recorded as follow: inhalation 53.2% (n=41), ingestion 
35.1% (n=27), rectal or vaginal 10.4% (n=8), and injection for 1.35% (n=1). Over 15.6% 
(n=12) received initial management on site, and 11.7% were given Narcan by the EMS 
technicians or immediately at arrival to ED. Decontamination only was ordered in 16.9% 
(n=13), observation only was done in 7.8% (n=6), 27.3% received decontamination with 
some other therapeutic measures, and 42.9 % received other therapy without 
decontamination. 
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Over 76% (n=59) of the psychotic patients that presented to ED for a poisoning 
related complaint reported smoking tobacco, and 61% (n=47) reported taking alcohol 
regularly. As many as 77.9% (n=60) of this group with documented psychotic disorders 
acknowledged to their ER physicians that they took illicit drugs.  Among the total 77 
patients in this group only 11.7% (n=9) of patients were discharged home, the rest 
(77.9%, n=60) were hospitalized. The final outcome was subjectively assessed as major 
in 49.4% (n=38), as a minor effect in 46.8% (n=36); no deaths occurred in this group. 
The average length of stay was 1.3 days and follow up after discharge was done in 87%, 
through outpatient clinics and primary care physicians. 
3.9.    Personal Medical History of other Mental Illnesses 
In the process of data collection, it was deemed logical to collect information on 
other mental illnesses that might be associated with depression and psychotic disorders 
that may influence the patient’s risk for self poisoning. However, the data was limited 
and only 3.5 % (n=19) had other concomitant psychiatric disorders such as generalized 
anxiety disorders, seen in 1.3% of the cases. 
3.10.    History of Smoking  
Since the review of literature has shown only rare cases of isolated tobacco 
intoxication where tobacco was the primary poison that necessitated emergency visit, 
smoking exposure was not initially considered the list of poisons of interest. However, an 
assessment of smoking status was included in order to assess its prevalence among ED 
related poisoning cases. Over 60.9 % (n=395) were tobacco smokers; smoking was self 
reported on admission and documented on the patient chart systematically as part of the 
initial H&P assessment.  
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FIGURE 21: Smoking and alcohol (ETOH2) co-morbidity by age.  
 
Smokers were aged between 17 and 72 years with a mean of 41.37 and a SD 
10.44. Over 41.7% were female and 58.3% male with a sex ratio of 1.4. Of the total 395, 
13.2% (n=52) were married and 71.9% (n=284) were single. Eighty two percent (n=324) 
of the smoking patients were African American, 5.1% (n=21) Hispanic, and 5.3% (n=21) 
White. Smokers’ rate of unemployment was 88.4% within our population. Over 34.7% 
(n=137) were covered by public aid, 5.8% (n=23) by Medicare, 1.5% (n=6) by Medicaid 
and the rest did not have any insurance coverage 46.1% (n=182). Patients arrived to the 
ED primarily by walking 29.9% (n=118) or by the Chicago Fire Department 54.2% 
(n=214). Their chief complaints were chest pain and heart related complaints (33.4%, 
n=132), shortness of breath (25.1%, n=99), unresponsiveness, confusion to coma (18.7%, 
n=74), drug overdose (11.1, n=44), vomiting (2.8%, n=11), and suicidal 
acknowledgement at arrival to ED for (1.3%, n=5). 
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Among the smokers’ group 15.9% (n=63) were diabetics, 36.5 % (n=144) had a 
history of chronic hypertension, 19.7% (n=78) had a history of cardio-vascular diseases, 
3% (n=12) had chronic arthritis and there were .8% (n=3) cases of diagnosed cancer. 
History of depression among smokers visiting ED for poisonings was noted in 19.2% 
(n=76) and history of psychosis was recorded in 14.9% (n=59). The proportion of regular 
alcohol drinkers among smokers was 73.4% (n=290) and a history of prior similar 
poisoning events that necessitated emergency visit was 47.6%. Among the same group, 
77.5% (n=306) presented to ED for illicit drug related poisoning, as opposed to only 
12.7% (n=50) for pharmaceutical drug poisoning and 9.1% (n=36) for industrial chemical 
poisoning. Tobacco smokers were poisoned with cocaine in 39.2% (n=155), heroin in 
35.9% (n=142), heroin cocaine combination in 4.8% (n=19), multiple drugs in 5.1% 
(n=20) salicylates in 2% (n= 8) and analgesics in 1% (n=4). Methadone, stimulants, and 
marijuana all together accounted for 1.3% (n=5). 
The route of the poisoning exposure in smokers was mainly inhalation in 70.6% 
(n=179) followed by ingestion in 12.4% (n=49), rectal and vaginal in 9.9% (n=39), and 
injection in 5.8% (n=23). Poison exposure in smoking patients was categorized as 
follows: drug and medicinal abuse for 85.1% (n=336), suicidal for 9.6% (n=38), misuse 
and unintentional for 1.8% (n=7) and therapeutic and adverse drug reaction for 2.5% 
(n=10). Over 19.5% (n=77) of cases received initial management intervention at the site 
of the exposure and another 13.4% (n=53) patients received injection of Narcan antidote. 
ED management among smokers consisted of decontamination only 15.4% (n=61), 
observation only 6.1% (n=24), decontamination and other therapy in 28.6% (n=113). 
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Among this group of smoking patients, there were 46% who were managed by using 
other means that does not include decontamination. 
History of drug abuse in poisoning related ED visits in tobacco smokers was 
reported to be 91.4% (n=361). As many as 65.3% (n=258) were admitted to ICU or to a 
department other than ED and only 20.8% (n=82) were discharged; no death was reported 
among poisoned smokers. After discharge from the hospital 82.8% of poisoned smokers 
were given an appointment for follow up in outpatient clinics or with their primary 
physician. Concomitant consumption of other prescription medication taken for any other 
reason but poisoning the day of the poisoning was as follow: Albuterol 24.3% (n=96), 
anti-hypertensive 7.8% (n=31), anti depressant or anti psychotic 5.1% (n=20), clonidine 
in 1.5% (n=6) and analgesics 1% (n=4). The average length of stay among the smokers 
group was .9 day. 
3.11.    History of Alcohol Intake 
 
This study also had an interest in assessing the prevalence of alcohol consumption 
and its effect on possible intoxication events, considering alcohol alone, or its 
involvement in potentiating other substances.   
Over 53.5% (n=347) reported alcohol intake routinely but the information 
available failed to provide a consistent assessment of the quantity taken and how often. 
Seventy four cases had unknown alcohol use and information was not available on the 
chart. Only 4 cases were missing altogether. The age ranged between 15 and 66 years, 
41.5% (n=144) female and 57.1% (n=198) male with a male to female ratio of 1.3. Sixty 
nine point five percent (n=241) were single and 15% (n=52) married. Over 81% (n=282) 
were African American, 5.8% (n=20) were Hispanics and 5.8% (n=20) were whites. 
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Most of the poisoned alcoholic group (87%, n=302) were unemployed. Only 34.9% were 
covered with IDPA, 44.7% (n=155) were self-payers, 6.3% (n=22) covered by Medicare, 
and 2% (n=7) by Medicaid. Chicago fire department (CFD) brought 51.9% (n=180), and 
28.8% (n=100) of alcoholic poison related patients visiting ED were walk in. twenty one 
percent (n=73) were confused or unresponsive, 31.1% (n=108) had a chief complaint that 
was heart related 21.6% (n=75) had shortness of breath and 13.8 complained expressed 
an overdose related event at arrival to ED triage system. Vomiting was a chief complaint 
in 2.9% (n=10), suicidal attempts was found in 2.6% (n=9) of cases, and one case of 
injury related poisoning. Diabetes mellitus was present in 14.4% (n=50), Chronic 
Hypertension in 34.6% (n=120), cardio vascular diseases in 20.2% (n=70), arthritis in 4% 
(n=14), asthma in 42.4% (n=147) and cancer in 1.7% (6 cases). 
Depression was present among alcohol users (22.2%, n=77) and diagnosed 
psychosis was present in 13.5% (n=47). The rate of smoking among alcoholics was 
83.6% (n=290), history of poisoning events that necessitated ED consultation was at 
48.1% (n=167) and history of illicit drug use was very high among them (92.2%, n=320).  
Among alcohol users, cocaine was the highest poisoning exposure (39%, n=135), 
then heroin (33.4%, n=116); heroin. Cocaine combination was seen in 4% (n=14) of 
cases. Though the rate of abuse is very high in this group, it seems that alcohol using 
patients are cautious with their intake in that the rate of alcohol related ED visits was very 
low (2.9%, n=10). It is important to note that alcohol intoxication might have been coded 
in a separate category other than poisoning, such as in an abuse category that is not part 
of this study. Multiple drugs were taken in 7.8% (n=27) of cases, aspirin intoxication in 
2% (n=7), anti depressors and antipsychotics in 6.1% (n=21), and unknown pills, 
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marijuana, analgesics stimulants, and methadone were 2.7% (n=9) of cases. The major 
route of exposure reported was inhalation with 66.9 (n=232), then ingestion in 16.1% 
(n=56), and rectal and or vaginal at 10.4% (n=36); in this group drug injection was seen 
in only 5.5% (n=19).  
The circumstances of poisoning was not much different from the smoking group 
as abuse represented 83.6% (n=290), misuse and un-intentional 2.1% (n=7), and 
therapeutic and adverse drug reaction were at 1.5% (n=5). Suicidal circumstance was 
high in poisoned cases with habit of regular consumption of alcohol at 11.6% (n=41) but 
not as high as suicidal poisoning among smokers. Twenty one point three percent (n= 74) 
were discharged, and 65.7% (n=228) were admitted to the hospital. Of the hospitalized 
patients, follow up was offered to 80.4 % (n=279). Patient reported that other prescription 
medications were taken within last 24 hours before the poisoning event as follow: 
albuterol in 21% (n=730), antidepressant anti psychotic 6.1% (n=21), and anti 
hypertensive in 7.5% (n=26). 
3.12.     History of Recreational Drug Use 
 
 
FIGURE 22: Prior History of illicit drug abuse by co-morbidity. Approximately 80% of 
the patients have had a history of prior use of illicit drug use.  
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Overall, 80% of the cases that presented to the ED reported past history or current 
use of illicit drugs for recreational use.  Among those 80% who voluntarily 
acknowledged the use of recreational drugs, 39.4% (n=256) were single heroin users 35.5 
% (n=231) were single cocaine users. Marijuana was only reported in 1.7% of the cases, 
this very low rate of marijuana related events could be explained by the low toxicity of 
marijuana that results in very rare cases of ED poisoning related visits, however similar 
to alcohol, some of the marijuana events could have been coded under a different code 
such as abuse instead of poisoning. Twenty nine percent (n=190) of patients who reported 
the use of at least 2 drugs concomitantly, such as: cocaine concomitantly with something 
else 14% (n=91), heroin with something else 5.1% (n=33) alcohol with something else 
5.7% (n=37) and 2.6% (n=17) who smoked marijuana while using another type of drug.          
4.0.   ANALYSIS OF ER MANAGEMENT & FINAL OUTCOME 
 
ED management included decontamination in only 16.9% (n=110) of cases, while 
combined decontamination with other therapeutic measure was seen in 28.5 % (n=185) of 
cases.  Seven point four percent (n=46) benefited from observation without any other 
intervention. Therapeutic measures were given to 43.1%. Only 2 cases were documented 
as refusing treatment offered (.3%). There were 25 cases (3.8%) where information 
treatment was missing. 
4.1- Initial Site Management Effect on the Final Outcome 
 
Of the total patients, over 34.7% (n=128) needed an urgent intervention at the site 
of the exposure and it was documented in the patients chart or in the Chicago Fire 
department transfer sheet attached to patients’ charts. No specific details about the 
intervention were collected, as it varied from simple perfusion to mechanical ventilation, 
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but the need for Naloxone administration on site or upon the patient’s immediate arrival 
to ED was captured. Fourteen point five percent (n=92) were found unconscious and 
Naloxone (Narcan®) administration was immediately administered at the site of the 
exposure or at arrival to ED in order to counteract the effect of the poison. 
 
 
 FIGURE 23: Major Outcome and final disposition by Initial Management at the Site of 
the poisoning event. Both the final outcome (OUTC_MAJOR) and the number of patients 
that were admitted (DISP_ADMITTED) to the hospital following a poisoning event 
depended on whether or not they have received initial management such as Narcan® 
injection or other treatment on the site of the poisoning.   
 
4.2.    Poisoning Final Outcome  
 
The outcome for each case is assessed and categorized into four categories: No 
effect; fair or minor effect; complicated or major effect; and death. Major effect was 
issued if the patient had been admitted to ICU, if he was injured; case resulted in 
permanent damage, long hospitalization or in a significant complication of his associated 
preexisting diseases.  
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In our series, there were 49% (n=318) major effects recorded, versus 45.3% minor 
effect and 3.8% were classified as no effect of the exposure on the patient. Death was 
recorded in .6% (n=4) cases. 
 
 
 
FIGURE 24: Rates of admissions by various co morbidities. Admission rates of the six 
above groups of patients with co morbidities ranged between 70% and 80%, but history 
of cardio vascular diseases was the highest group to be hospitalized. 
 
Of the cases that were classified as major effect, there were 37.9% (n=118) 
female and 62.1% (n=194) male cases aged between 14 and 80 years old. Eleven point 
nine percent (n=38) were suicidal and 83.3% (n=265) had used an illicit drug for the 
purpose of recreation. Fourteen point five percent of them were married and 68.6% were 
singles, 80.5 % were African American. Sixteen point four percent of the total 318 
patients arrived to ED unresponsive or confused, 36.8% presented with a heart related 
complaint and 28.3% were short of breath. There were 16.4% (n=52) were diabetics, 
36.5% (n=116) had hypertension, 23% (n=73) had cardiovascular diseases and 47.2% 
(n=150) had chronic asthma. In this group the adverse outcome of depression was present 
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in 20.8% (n=66), psychosis in 11.9% (n=38). Sixty seven percent (n=213) of tobacco 
smokers and 59.4% (n=189) of alcohol users. Heroin exposure resulted in a major 
outcome in 29.9% (n=95), cocaine in 44.3% (n=141), multiple drugs intoxication in 5% 
(n=16), and anti-depressors in 5.3% (n=17). 
 
4.3- Correlation of Outcome and Emergency Site Management 
 
A significant relationship (F= 6.035, DF=2 and p= .003) was found between the 
type of the initial on-site management and the final outcome. Patients who had some kind 
of management on the site of the exposure seemed to have recovered better. A significant 
relationship was also seen between final disposition, and initial site management 
(F=20.37, DF=2, p= .0001). 
4.4.    Prior History of Poisoning 
Over 40% (n=265) of patients reported prior history of poisoning that needed a 
visit to ED, and were documented and verified in their charts. Of these 265 cases 17.2 % 
(n=112) overdosed with heroin and 18% (n=117) overdosed with cocaine. 
 
FIGURE 25: Documented prior history of poisoning and illicit recreational drug uses by co-
morbidity.  
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One point four percent (n=9) were poisoned with heroin in association with a second 
agent, and 3.7% visited the ED for cocaine poisoning concomitantly with something else. 
In summary, there were 6.6% (n=43) cases had a history of double agent poisoning and 
1.1 % (n=7) had triple agent poisoning. 
 4.5.   Follow-Up 
 
As shown in figure 27, over 80.8% (n=525) of patients were sent for follow up to 
the outpatient services or to their primary care physician, of these 525 patients 64.8% 
(n=340) were sent to outpatient care and 17.5% (n=92) were sent to their primary care 
physician (PCP). 
 
FIGURE 26: Percent of after hospitalization follow-up. Approximately 20% of the total 
cases were lost for follow up. 
 
4.6.    Final Disposition  
Overall, 62.9% (n=409) of patients required further management measures other 
than that received in the emergency department, and were transferred to inpatient 
services. Seventy eight percent were admitted to the emergency department for 
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observation, .6% (n=4) died, and the remaining 22.5% (n=146) were discharged except 
for 2.2% (n=14) which were missing and may represent cases that left against medical 
advice or eloped from the emergency department.  
More males 62.1% (n=90) than females 37.9% (n=55) were discharged from ED, 
and the age median was 40 years for this group of patients. This may indicate that more 
females were hospitalized because their poisoning event looked more serious or because 
they did not respond to the initial management in ED.  
 
Figure 27: Final disposition distribution. Most patients were transferred to 
another department in the same hospital, approximately 10% were admitted to ED for 
observation and around 20% were discharged. 
 
Among the group of patients that were discharged from ED, 79.5% (n=116) of 
them had an event related to the use of a recreational drug, 15.1% (n=22) from the use of 
pharmaceutical drugs and 4.8% (n=7) were poisoned with a chemical that was industry- 
based.  
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In the Admitted group, patients’ ages varied between 1 and 85 years, mean 40.69 
(+/- SD 13.067), 45.2% were females and 54.8% were males; 70.2% of them were single 
and 11.2% married; 65% were exposed to illicit drugs and 23.5% to pharmaceutical 
drugs.  
Over 47.2% (n=193) were asthmatics, 35% (n=143) had chronic hypertension, 
22.7% (n=93) had cardio vascular disease, 4.4% (n=18) had chronic arthritis, and 1.2% 
(n=5) had a malignancy. Depression was present in 25.9% of the hospitalized group, 
psychosis in 14.7% (n=60), smoking in 63.1% (n=258), and alcohol use in 55.7% 
(n=228). Suicidal poisoning were present in 16.1% (n=66) and abuse in 73.8% (n=302); 
their average length of stay was 1 day. 
 
 
FIGURE 28: Admissions and discharge were highest during the first shift then decline 
sharply during the third shift (Disp_Disch: disposition discharged; Disp_Admitted: Disposition 
Admitted to hospital, disposit. 4= died). 
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5.0- ANALYSIS OF CORRELATION 
One of the primary interests of this study was to explore the significance of the 
relationship between asthma and heroin use in the population of ED that was reported in 
the literature, for which many mechanisms were speculated, but none confirmed. In fact 
Chicago has one of the highest mortality rates and prevalence of asthma, and also one of 
the highest prevalence of drug abuse which makes these two variables of special interest 
for this study. 
After checking the observations’ independence and verifying the normality of the 
population, bivariate analysis with computation of both a Pearson test and a (2-tailed) t 
test was performed. It is a measure of correlation that varies between -1 and +1, with 0 
indicating no relationship (random pairing of values) and 1 indicating perfect 
relationship, i.e. "The more the x, the more the y, and vice versa." A value of -1 is a 
perfect negative relationship, i.e. "The more the x, the less the y, and vice versa. R square 
is the coefficient of determination, the square of the Pearson correlation coefficient, and it 
represents the percent of the variance in the dependent variable explained by the 
independent. The significance level of the Pearson test was set at 0.01 
After bivariate analysis, a partial correlation test was performed. Both the 
bivariate and the partial test have shown a statistically significant relationship between 
asthma and heroin use with coefficient at (r= .175, DF=647, p=0.001). This relationship 
is positively correlated, indicating that an increase of one variable results significantly in 
an increase of the second and may be explained as such: the overuse of heroin may 
exacerbate asthma. Or the opposite effect could also be true: when having a history of 
asthma this may predispose this group of patients to over-use heroin, knowing that the 
 
  
latest research is pointing toward genetic predisposition for both of them (Matthias 2007, 
Xuei et al., 2007, Balaci, 2007)  
The bivariate correlation (2 tailed) t test showed a strongly significant correlation 
between heroin and asthma with (r=.175, p= .0001).  An “r” partial Pearson correlation 
test, which gives the advantage of correcting for the effect of other confounding factors 
by blocking the effect of other variables that may participate in the correlation of interest, 
was also performed. 
After correcting for the effect of depression, psychosis, smoking, alcohol, ASA 
exposure, prior history of poisoning, anti-depressor and anti-psychotic drugs, methadone, 
and cocaine exposure, it was found that the significance between asthma and heroin 
disappeared, and the Pearson coefficient dropped to .074, the p value increased to 0.061, 
becoming statistically non significant. This could be interpreted to mean that there was no 
true correlation between variables of interest.  
5.1- Depression Correlations 
Depression was significantly correlated with the variable suicidal attempt (r=.275, 
DF=647, p=.0001), and with multiple drugs exposure, (which is most likely deliberate 
intake for the purpose of suicide or abuse), (r=.136, DF=645, p=.001). Another 
significant relationship was found between depression and history of psychosis (r= .352, 
DF=647, p= .0001) and between depression and the exposure to anti-
depressors/antipsychotic drugs (r= .215, DF645, p= .0001), as well as with the use of 
ASA (p=.172, DF=645, p=.0001). Heroin exposure was negatively correlated to 
depression (r=-.200, DF=645, p= .0001). 
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 As far as the route of exposure the bivariate analysis has shown that ingestion 
route was significantly correlated (r=335, DF=647, p=.0001), inhalation route was also 
found significant but it was negatively correlated (r=-175, DF=647, p=.0001). 
Disposition was categorized in discharge, admission to the hospital and death. The 
analysis revealed that depression and discharge from the hospital were negatively 
correlated (r=-.103, DF=647, p= .009). Depression and admission to the hospital were 
positively correlated (r= .138, DF=647, p=.0001), which simply translates to an 
unfavorable prognosis of poisoning when depression was present. This could also be due 
to the higher dose intake of the drug due to the presence of depression or it may be due to 
the choice of the drug itself that is different when the patient is depressed and having 
suicidal thoughts. 
The poisoning agents were categorized as: pharmaceutical drugs/medications, 
chemical domestic, chemical industrial, or occupational and recreational exposure. Only 
pharmaceutical drugs/medications were significantly correlated to depression (r= .307, 
DF=647, p=.0001). 
Suicidal poisoning were positively correlated (r= .453, DF=647, p=.0001), abuse 
was also significantly correlated to depression (r= -.305, DF=647, p=.0001) 
TABLE 2: Summary list of depression significant Correlations. 
Variable 1 Variable 2 R DF p Value 
Depression ASA .172 645 .0001 
Heroin -.200 645 .0001 
Admission to Hospital .138 647 .0001 
Pharmaceutical drugs  .307 647 .0001 
Suicidal poisoning .453 647 .0001 
    
 
60 
 
  
5.2- Psychotic Disorders  
Psychosis was significantly correlated to depression as previously mentioned, to 
heroin (r= -121, DF=645, p= .002), to smoking (r=.118, DF=647, p= .003), to insurance 
coverage (particularly IDP) (r=129, DF=647, p= .001) and self-coverage (r= -.137, 
DF=647, p=.0001). Similar to depression psychotic disorders were also found to be 
significantly correlated to prescription medication of anti-depressant and anti-psychotics 
(r= .190, DF=645, p=0001), which is generally their prescription medication and to 
ingestion the route (r=.125, DF=647, p= .001). 
Admission disposition is also strongly correlated with psychotic disorders (r= 
.113, DF=647, p= .004) as well as to pharmaceutical drugs (r= .114, DF=647, p= .004). 
Suicidal circumstance was also significantly correlated with psychotic disorders (r= .163, 
DF=647, p= .0001) and to abuse circumstances (r= .102, DF=647, p= .009). 
 
TABLE 3: Psychotic disorders significant correlations with poisoning. 
 
Variable 1 Variable 2 R DF p Value
Psychosis Co-morbidity 
Smoking .118 647 .003 
Insurance IDP .129 647 .001 
Anti-Depr/Anti-Psych .190 645 .0001 
Ingestion route .125 647 .001 
Admission .113 647 .004 
Prescription drugs .114 647 .004 
Suicidal poisoning .163 647 .0001 
Illicit drug abuse .102 647 .009 
 
 
5.3- Heroin Poisoning Correlations 
Heroin was found to be correlated to many other variables in our population, such 
as depression, psychosis, cardio vascular diseases (r= -.181, DF=644, p= .0001), to 
cocaine (r= -.508, DF=645, p= .0001), to abuse of heroin and cocaine combination (r= -
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.158, DF=645, p= .0001), to multiple drugs exposure (r= -.180, DF=645, p=000), history 
of drug abuse (r=286, DF=635, P=000), to the Hispanic race (r=-146, DF=645, p=000), 
to self insurance (r=212, DF=644,p=000), to arrival by CFD (r=213, DF=643, p=000), 
arrival to ED by walking (r= -.143, DF=645, p=000), chief complaint Unresponsive 
(r=152, DF=645, p=000), chief complaint heart related (r=0.268, DF=645, p=000), 
shortness of breath chief complaint (r=177, DF=645,p=000), Aspirin intoxication (r= -
.139, DF=645, p=000), anti depressor/anti-psychotic exposure (r= -139, DF=645, p=000), 
ingestion route (r=-359, DF645, p=000), rectal vaginal route (r=.350, DF= 645, p=000), 
management at the site of the exposure (r=.111, DF=630, p=000), suicidal poisoning (r= -
.234, DF=245, p=000), circumstance abuse (r= 324, DF645, p=000) and concomitant 
intake of other substances (r=.258, DF=645, p=000). 
 
TABLE 4:  Summary of heroin poisoning correlations. 
 
Variable 1 Variable 2 R DF p Value 
Heroin Poisoning 
Vaginal or rectal route .350 645 .0001 
History of drug abuse .286 635 .0001 
Heart related CC .268 645 .0001 
History Illicit drug abuse .324 645 .0001 
SOB (CC) 
Asthma 
.117 
.174 
645 
645 
.0001 
.0001 
Depression -.118 644 .0001 
Suicidal poisoning 
 
-.234 
 
645 
 
.0001 
 
 
5.4- Cocaine Poisoning Correlations 
Cocaine was found to be significantly correlated to chronic hypertension (r= .220, 
DF=745, p=.0001), and to cardiovascular diseases (r= .227, DF=645, p=0001. Cocaine 
was also significantly correlated to heroin, to heroin cocaine combination, (r= -145, 
DF=745, p=000), to multiple drugs (r=-.166, DF=645, p=000), to smoking (r=201, 
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DF=645, p=000), and to the habit regular alcohol intake (r=.165, Df=645, p=000), to 
history of drug abuse(r= .245, DF=645, p=000, ), to age (r= .227, DF=645, p=000), to 
race White (r=-.140, DF=645, p=000), arrival mode through CFD (r=-149, DF=645, 
p=000), arrival walking (r=173, Df=645, p=000), chief complaint unresponsive (r=-.234, 
Df=645, p=000), chief complaint heart related symptoms such as chest pain (r= .507, 
Df=645, P=000), chief complaint vomiting (r=-.200, Df=645, p=000), anti depressors and 
anti psychotic exposure (r=-.173, Df=645, p=000), ingestion route (r= -.353, DF=645, 
p=000), inhalation (r=.430, Df=645, p=000) to rectal/vaginal (r=-.225, DF=645, p=000), 
to outcome minor (r= -.222, DF=645, p=000), to major outcome (r= .266, Df=645, 
p=000), to discharge disposition ( r= -.274, DF=645, p=000), admitted disposition 
(r=.181, DF=645, p=000), exposure to medication and pharmaceutical products (r=-.353, 
DF=645, p=000), to recreational drugs (r=283, DF=645, p=000), suicidal category of 
exposure (r= -.258, DF=645, p=000).  
 
TABLE 5: Significant correlations with cocaine poisoning. 
 
Variable 1 Variable 2 R DF p Value
Cocaine 
poisoning 
Inhalation .430 645 .0001 
Major outcome .266 645 .0001 
Chest pain .507 645 .0001 
History of drug abuse .245 645 .0001 
Age .227 645 .0001 
History of Illicit drug abuse .283 645 .0001 
Unresponsiveness -.234 645 .0001 
Hospital admission .181 645 .0001 
Antidep/antipsych .173 645 .0001 
Prescription medications  -.353 645 .0001 
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6.0.  PREDICTION ANALYSIS 
One of the interests in this study is to determine predictors for the final outcome 
of ED poisoning, which could be useful for improving patients’ management and also in 
implementing preventive measures. Predictors for poisoning final outcome, asthma, and 
for the risk of suicide in our population were computed using regression analysis.  
The stepwise regression analysis for outcome resulted in the construction of the 
following models.  
Final Outcome of Poisoning = 0.108 + 0.200 * Cocaine + 0.114 * Inhalation + 0.121 * 
CVD + 0.103 * Asthma + 0.94 * Gender + 0. 09 * Prior Poisoning History 
 
Cocaine was the most predictive for the major outcome of poisoning, route of 
inhalation was the second most important predictor. Cardiovascular diseases were third, 
asthma, gender and prior history of poisoning. 
Stepwise regression analysis was also run to compute predictors for the risk of 
suicide attempts using poison. Predictors’ intercept and coefficient, as well as the 
significance of the overall model and the individual models produced, as well as the 
regression assumptions described in addendum 1. Measures of association are expressed 
in the following mathematical formula:  
 Model (Suicide) = 0.394 +0.330 *Depression -0.005* Age -0.99* Gender+ 0.072* Prior 
poisoning history-0.055-0.082*unemployed 
 
Depression is the greatest risk factor for suicide attempts; age and gender, prior 
poisoning event, and employment were also significantly correlated to suicide, and 
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remarkably, psychotic disorders, though known for their possible risk for suicide, 
particularly, in younger schizophrenics, our data did not support this assumption.  
A stepwise regression was performed for both asthma as a dependant variable and 
heroin as an independent with the assumption that heroin affects asthma and exacerbates 
it. The measure of association was expressed in the following mathematical formula:  
Model (Asthma) = 0/419 + 0.221 *Inhalation + 0.147 Prior Poisoning History. -0.140 * 
Gender + 0.149 * Heroin + 0.728 Cancer + 0.136 * Race_AA – 0.004 * Age 
 
Again, inhalation is the greatest predictor of asthma with prior history of abuse, 
heroin, gender, age, and race of African American being the most other important 
predictors for asthma (Table 9, Table 10). 
Similarly, another regression was run and asthma was the independent variable to 
check on the assumption that asthma predisposes patients to abusing heroin. The measure 
of association is expressed in the following formula: 
Model (Heroin) = 0.284 + 0.794* Rectal/Vaginal route + 0.142* Asthma + 0.273 * 
Inhalation + 0.394*Injection – 0.193* CVD – 0.110* Prior documented Poisoning 
history – 0.077* Alcohol + 0.111 * Psychosis 
 
Asthma was second strongest heroin abuse predictor (Table 3, Figure 41, 42, 43). 
This could also be that the observed correlation might indicate asthma is predisposing 
heroin addiction, or at least that the overall association is just a mixed effect from both 
variables in both directions. Inhalation is also a predictor of heroin abuse.  
Rectal and vaginal route of drug use is also very prevalent in heroin abusers. Psychosis is 
also a predictor of heroin abuse, which supports the study’s third hypothesis.  
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DISCUSSION 
 
 
Poisoning in the emergency department is still a problem, especially when it 
relates to the use of recreational drugs. The magnitude of this problem has been explained 
elsewhere, however its implications in ED, have been actively illustrated in this 
investigation. 
In exploring the relationship between asthma and heroin, our data revealed that 
there are two other significantly correlated co-morbidities with drug abuse, particularly 
chronic hypertension and cardiovascular diseases that were correlated to cocaine use. In 
reviewing the literature, we were unable to find any evidence of similar correlations, 
though, in our study it was found to be strongly correlated (r= .220, DF=745, p=.0001) 
for hypertension and (r= .227, DF=645, p=0001) for cardio vascular diseases. While the 
relationship of asthma to drug abuse is complicated, and many authors have suggested 
numerous theories to explain how heroin correlates to asthma, hypertension correlation to 
cocaine might be due to a more direct effect of cocaine on vessels. In fact, cocaine was 
extensively studied, especially its effect on enzymatic modulation and its ability to affect 
the fate of cell necrosis and apoptosis in the liver (Harbison et al., 2003, Harbison et al. 
2000, Price et al. 1999). Cocaine has also been shown to have numerous other effects on 
the cell signaling system and on the vascular bed by modifying the peripheral resistance 
and inducing a potent vasospasm that raises the blood pressure and increases the cardiac 
output. The vasopressor effects of cocaine are mostly mediated by norepinephrine of 
sympathetic nervous system (Hollander et al. 2008). By the same mechanism, cocaine 
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induces a vasoconstriction in coronary vessels and results in chest pain that mimics 
unerringly an angina or a myocardial infarct. Cocaine abusers may present chest pain 
similar to angina or coronary infarct which could result in a hospitalization. On 
discharge, a patient will generally be categorized as having a history of chest pain that 
will be documented in the patient’s medical history but without any mention of its 
temporal relationship to cocaine. This type of documentation might have interfered with a 
more accurate heart assessment and resulted in significant misclassification of cases in 
the cardiovascular diseases group. As a result, an apparent correlation of cocaine to heart 
disease might have been seen as a result of this misclassification. In summary, the 
apparent correlation of hypertension to cocaine might just be due to the direct effect of 
cocaine on the vasculature and in the case of cardiovascular disease and it seems that 
some of these cardio vascular co morbidities that were captured were partially, if not 
totally, cocaine-related diagnoses 
In a study conducted in ED to assess the prevalence of cocaine use in patients 
with hypertension who presented to ED for complaints not related to cocaine use, the 
author reported that only 13% of the total 99 cases of hypertension tested positive for 
cocaine, and 38% of them presented for chest pain or for congestive heart failure and 
were prescribed beta-adrenergic antagonist medications. In our series, the prevalence of 
cocaine admissions among hypertension patients was 47.2% (n=94) which is higher 
compared to what was previously reported. 
As a result of the high prevalence rate of heroin and cocaine use in our 
population, it is unlikely that patients who have underreported their drug use have 
affected the results of our study. The higher prevalence of drug use cannot be explained 
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by over reporting because patients are more likely to underreport than to over-report the 
use of controlled substances. However, even if they have underreported, one would 
expect our observed difference to be even larger. Thus, if any drug controlled user was 
incorrectly misclassified into a non-user group rather than a user group, our results would 
be expected to show a higher difference. 
Many cases were reported in recent years in relation to sudden and severe asthma 
incidents that were temporally correlated to the abuse of cocaine and heroin, and 
numerous authors report this relationship. They further conclude that heroin may be 
triggering asthma attacks and that heroin associated withy status asthmaticus. Another 
study reviewed death reports in the state of Maryland and demonstrated that a high 
percentage of patients who died from asthma had also abused drugs and their post 
mortem urine drug tests were positive (Weitzman et al.). 
Over 4% of all admissions for asthma in the US require mechanical ventilation, 
though there is still controversy regarding the optimal treatment for severe asthma 
requiring intensive care optimal intubations; some authors have also reported that many 
of the asthma patients requiring intubations are heroin abusers.  
Asthma patients, it seems, tend to use various drugs for abuse, and both legal and 
illicit drugs were described to be abused by asthma patients, including illegal inhalers 
(Thompson et al., 1983) and prescription drugs (including the ones that were not widely 
used by others such as glucorticoids, and inhalers salbutamol) (Kinirons, 1983. Quddusi 
et al. 1998). There was also a study conducted that was designed to compare tobacco and 
alcohol use in asthmatic students to non-asthmatics. This study found that high school 
students with current asthma used cigarettes, cigars, marijuana, and inhalants (huffing) at 
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rates greater than high school students without current asthma (Boyd et al. 2006; Jones et 
al. 2006).  It appears that asthma patients are subject to higher abuse susceptibility; this 
might be due to many reasons. The high anxiety of asthmatics could drive asthma patient 
to reduce their level of anxiety by abusing various drugs. There is still much to know 
about asthma co-morbidities, in particular its associated behavioral changes and effect on 
patients’ psychological well being. Recently Blackman et al. (2007) reported that 
children with asthma have higher rates of attention deficit/hyperactivity disorders; 
diagnoses of depression, behavioral disorders, learning disabilities, and missed school 
days. Behavioral changes were also seen in the adult population, and the effect on asthma 
management has always been a concern for increased morbidity and mortality in asthma. 
(Volicer et al. 2006). Moreover, there is evidence that drug dependence can run in 
families and that a person's genetic makeup can affect how the body processes a drug, 
and could also determine the drug's effect. These individual differences can make some 
people more likely to use drugs and to become dependent upon them. 
Due to its prospect in therapeutic and its role as an analgesic, heroin’s mode of 
action and mechanism of abuse and dependence has been heavily studied; particularly its 
genetic aspect where basic animal research and human studies have shown that complex 
genetic mediators exist, many gene and receptors are implicated in this behavioral aspect 
of heroin addiction. (Xuei et al., 2007) 
The relationship between asthma and heroin poisoning has been seen in previous 
reports from an asthma management point of view; heroin and asthma were observed to 
be temporally related. It was then concluded that heroin exacerbates asthma but a 
mechanism could not be established. Though this approach seems simple but logical, 
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researchers are skeptical of a receptor mediated effect on the bronchus as opiates favor 
blocking bronchoconstriction through these receptors instead of stimulating it. 
Researchers have also argued that the heroin effect on bronchoconstriction might occur 
through a non-receptor mediated mechanism that might also potentiated by an 
inflammatory response. No supporting evidence has been produced regarding this theory 
other than heroin may deregulate mast cells and release histamine.  
Depression has been described in the literature as a risk factor for poisoning 
because of the suicidal tendency that generally accompanies depressed patients. Our data 
has reinforced this belief and illustrated a strong relationship between suicidal intent 
using poison. Suicidal intent was found to be positively correlated (r=.453), which 
statistically translate into an r squared that is equal to .205. This value may be described 
as:  over 20% of suicide events seen in ED were attributed to this preexisting depression. 
Though depression as a risk factor has been previously reported, little description of the 
magnitude of the depression contributes in causing patients to commit suicide using 
poison. In our series, and according to our data, this component was estimated to 20.5%.  
It is known that there are certain triggers, for depressed patients with suicidal 
thoughts, which intensify suicidal urges. The question that remains unanswered is how 
much drug addiction is related to the modification, intensification, or renewal of suicidal 
triggers in comparison to non-addicted, depressed or psychotic patients. How much 
impact does drug addiction have on decision capabilities regarding self harming, 
assuming that he or she is in fact under extremely high stress from his or her need for 
drugs, and additional stress that originates from his or her depressed mood or psychotic 
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illusion. If that is the case, what determines the patient’s behavior in choosing the dose, 
the method, and the timing for shifting from intent to action? 
In this study, psychotic disorders were also identified as being significantly 
correlated with suicide attempts, but the coefficient of significance was relatively smaller 
than the one seen in depression. The Pearson’s coefficient was r =.163 which translates to 
only 2.6% of suicidal effect that can be attributable to preexisting psychotic disorders. 
However, another correlation was also established between psychosis and the use of anti-
psychotic and anti-depressors that could indicate that patients with psychotic disorders 
are subject to the risk of auto intoxicating themselves by using their own prescription 
medication. A similar pattern was seen in patients with depression that are under tricyclic 
medication, but this scenario is even more complicated with anti-depressors given the 
fact that these medications have a very narrow safety window, and many depressed 
patients overdose unintentionally. Patient education regarding tricyclic toxicity has 
become routine now after all the accidents that were seen in ED. Moreover, the current 
recommended best practice is to limit the prescription of tricyclics antidepressants in 
favor of the newer selective serotonin reuptake inhibitors (SSRI).  
Poisoning and drug addiction remain a significant burden on the healthcare 
system, particularly on the asthmatic. Our follow up cost study was designed to compare 
asthmatics with a history of drug addiction and poisoning to another group of asthmatics 
without any history of drug poisoning or addiction. Both groups were compared with 
respect to length of stay (LOS) inpatient, age, gender, and expenditures. The mean LOS 
for asthmatics without drug abuse was 1.21 days and a SD of .695, and for the asthmatic 
patient with history of illicit drug poisoning of 7.07 days. The hospital charges ranged 
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between $99.00 and $18096.00 with a mean of $2941 for asthmatic without abuse and 
between $52.00 and $695874.00 with a mean of $28028.00 for the group of asthmatics 
with illicit drug poisoning. A significant difference was established (p<.001) between the 
LOS of asthma with heroin and/or cocaine abuse as compared to LOS of asthma without 
abuse, and a significant difference in hospital cost was also established between the 2 
groups (p< .0001.). 
There are several potential limitations to this study. The study is retrospective and 
the information was collected from the patients’ charts, which varied in accuracy and 
availability between cases. Due to the high rates of drug abuse history, it does not seem 
that this study underestimated the abuse; however it might have underestimated some co-
morbidity such as arthritis, and particularly depression, which is still not screened 
systematically for every patient visiting ED, especially in a setting of drug overdose 
emergencies. Another potential limitation of this study was that there was no way for the 
study to follow up on specific cases and screen patients for suicidal ideation to find out if 
they have had any intent for self-harm.  
One of the other limitations to this study is inherent to case capture, given the 
initial design that did not take in consideration the complexity of the coding process. 
Unfortunately this issue was discovered after the data collection started; in fact cases like 
alcohol poisoning were not coded under poisoning, but under abuse, and similarly, 
marijuana use was not captured under poisoning, but under a separate code. In the case of 
alcohol and marijuana use, our study has accounted mainly for events with overdose that 
resulted in significant effects. Similarly, adverse drug reaction and therapeutic poisoning 
were not coded under poisoning unless they resulted in a significant effect. The study aim 
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was not adverse reaction, marijuana or alcohol abuse, which was the reason why these 
deficiencies did not affect the validity of the study results nor its ability to be generalized. 
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CONCLUSION 
 
In conclusion, the findings of this research supported the hypothesis that drug 
abuse is the greatest risk factor for poisoning in the emergency department over 
prescription drugs, environmental and occupational exposures. This research has shown 
that there is correlation between chronic diseases and intentional poisoning using illicit 
drugs, in particular cocaine and heroin. This study has also shown a correlation between 
chronic hypertension and cocaine, cardiovascular diseases and cocaine, and a correlation 
between asthma and heroin abuse. Our data has verified that there is an ongoing change 
in illicit drug route of intake that is shifting from injection to inhalation; expectantly this 
shift will have a positive effect on reducing the prevalence of HIV and hepatitis B in the 
future. However, it seems that the heavy use of illicit drugs through inhalation has 
resulted in novel problems to asthma patients. A measure of association was established 
between asthma and heroin use, and inhalation was found to be the greatest predictor for 
asthma in this population. 
The results suggest that suicidal behaviors are not infrequent occurrences among 
drug users, and that they often coexist and complicate other medical conditions. 
Predictors for suicide attempts were produced, and it was determined that interventions 
designed to reduce suicidal behaviors should simultaneously address preexisting medical 
conditions that could predispose or increase the patient’s risk for transitioning from 
ideation to action. Rates of depression and associated psychotic disorders in drug addicts 
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with asthma indicates a need to systematically screen young and middle aged adults with 
asthma and drug abuse for depression and for suicide risk.  
This study provides evidence supporting the idea that heroin and cocaine abuse 
are serious issues that significantly raise the cost of asthma and increase both the rate of 
hospitalization and hospital LOS. Pragmatic guidelines and innovations in reducing 
heroin and cocaine abuse in patients with asthma may improve the severity of the disease, 
and reduce its burden on the healthcare system and on society. 
This research was able to characterize the circumstances of incidents of poisoning 
and provide a greater understanding of the extent of this problem and its burden on 
patients and on society. It has also identified numerous predictors that can be used by 
healthcare organizations, practitioners, and health policy makers for improving the 
management of asthma and its complications that result from drug use. This study has 
helped in consolidating a considerable amount of information on co-morbidity, drug use, 
smoking and alcohol prevalence that may be very useful for patient management and 
future research. 
Drug abuse is a burden on asthma patients, particularly those that are not covered 
by insurance. Asthma education and self-management techniques in patients 
acknowledging the use of recreational drugs, specifically heroin or cocaine by 
insufflations, need to be provided and patients must be informed about the potential risk 
and educated on how to prevent significant asthma exacerbation by avoiding common 
triggers, drug use, and other additional stress. Enrollment of asthma patients in free drug 
rehabilitation programs may be the way of the future; these programs can be sponsored 
by the state or by insurance companies. Similar programs will cut down significantly on 
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asthma costs that are still a top public health concern in many states such as the state of 
Illinois. The magnitude of loss from the additional burden that poisoning is placing on the 
society and on insurance companies, as well as on asthmatics, can be minimized if similar 
steps were taken.  
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APPENDIX A:  MODELS CALCULATION TABLES 
 
 
 
 
TABLE 6: Model Summary for Poisoning Final Outcome 
 
Model Sum of Squares df Mean Square F Sig. 
6 Regression 19.545 6 3.257 14.796 .000f 
Residual 131.655 598 .220   
Total 151.200 604    
 
a. Predictors: (Constant), Cocaine    
b. Predictors: (Constant), Cocaine, INHALATION   
c. Predictors: (Constant), Cocaine, INHALATION, P_POISON_HIS  
d. Predictors: (Constant), Cocaine, INHALATION, P_POISON_HIS, 
CVD2 
 
e. Predictors: (Constant), Cocaine, INHALATION, P_POISON_HIS, CVD2, ASTHMA2 
f. Predictors: (Constant), Cocaine, INHALATION, P_POISON_HIS, CVD2, ASTHMA2, 
Gender 
g. Dependent Variable: OUTC_major    
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TABLE 6 (Continued): Model Summary for Poisoning Final Outcome  
 
Coefficients 
 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
6 (Constant) .108 .070  1.552 .121 
Cocaine .200 .047 .186 4.283 .000 
INHALATION .114 .046 .111 2.489 .013 
P_POISON_HIS .090 .041 .089 2.215 .027 
CVD2 .121 .052 .092 2.336 .020 
ASTHMA2 .103 .042 .101 2.466 .014 
Gender .094 .039 .094 2.401 .017 
 
 Model for Final Outcome of Poisoning = 0.200*Cocaine + 0.114 * Inhalation + 0.121 
* CVD + 0.103 * Asthma + 0.94 * Gender + 0.09 * Prior Poisoning History 
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TABLE 7: Stepwise Regression Model Summary for Suicidal Predictability. 
Model Summary 
Mode
l 
R R Square Adjusted R 
Square 
Std. Error of 
the Estimate
Change Statistics 
R Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 .453a .206 .204 .304 .206 161.427 1 624 .000 
2 .505b .255 .253 .295 .050 41.508 1 623 .000 
3 .519c .269 .266 .292 .014 11.931 1 622 .001 
4 .534d .285 .281 .289 .016 13.884 1 621 .000 
5 .540e .291 .286 .288 .006 5.498 1 620 .019 
6 .545f .297 .290 .287 .006 5.085 1 619 .024 
Coefficients 
Model 
Unstandardized 
Coefficients Standardized Coefficients 
t Sig. B Std. Error Beta 
6 (Constant) .394 .074  5.285 .000 
DEPRESSION2 .330 .028 .398 11.617 .000 
Age -.005 .001 -.195 -5.656 .000 
Gender -.099 .024 -.144 -4.149 .000 
PP.doc.his .072 .024 .104 2.962 .003 
ASTHMA2 -.055 .024 -.079 -2.256 .024 
unemployed -.082 .036 -.077 -2.255 .024 
 
Predictors Model (Suicide) = 0.394 +0.330 *Depression - 0.005* Age -0.99* Gender + 
0.072* Prior poisoning history - 0.055 -0.082*unemployed. 
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TABLE 8: Heroin poisoning Predictors Model Summary 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
Change Statistics 
R Square 
Change F Change df1 df2 
Sig. F 
Change 
1 .351a .123 .122 .449 .123 87.441 1 624 .000 
2 .423b .179 .176 .434 .056 42.557 1 623 .000 
3 .461c .212 .209 .426 .033 26.366 1 622 .000 
4 .500d .250 .245 .416 .037 30.942 1 621 .000 
5 .523e .273 .267 .410 .023 19.940 1 620 .000 
6 .531f .281 .274 .408 .008 7.152 1 619 .008 
7 .537g .288 .280 .406 .007 5.968 1 618 .015 
8 .542h .294 .285 .405 .005 4.800 1 617 .029 
 
TABLE 8: (Continued) 
a. Predictors: (Constant), RECTAL_VAGINAL 
     
b. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2      
c. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION     
d. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION    
e. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION, 
CVD2 
   
f. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION, CVD2, 
PP.doc.his 
  
g. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION, CVD2, PP.doc.his,   
h. Predictors: (Constant), RECTAL_VAGINAL, ASTHMA2, INHALATION, INJECTION, CVD2, PP.doc.his, 
 Dependent Variable: Heroin       
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TABLE 8 (Continued): Heroin poisoning Predictors ANOVA and Model Coefficients 
ANOVAi 
Model Sum of Squares df 
Mean 
Square 
F Sig. 
8 
Regression 42.078 8 5.260 32.087 .000h 
Residual 101.141 617 .164   
Total 143.220 625    
Model Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients t Sig.
B Std. Error Beta 
8 
(Constant) .284 .079  3.576 .000
RECTAL_VAGIN
AL 
.793 .061 .511 13.019 .000
ASTHMA2 .142 .035 .146 4.060 .000
INHALATION .273 .043 .278 6.414 .000
INJECTION .394 .080 .183 4.896 .000
CVD2 -.193 .043 -.153 -4.484 .000
PP.doc.his -.110 .035 -.113 -3.110 .002
ETOH2 -.077 .033 -.080 -2.306 .021
PSYCH2 -.111 .051 -.075 -2.191 .029
a. Dependent Variable: Heroin     
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Model (Heroin) = 0.284 + 0.793* Rectal/Vaginal route + 0.142* Asthma + 0.273 * 
Inhalation + 0.394*Injection – 0.193* CVD – 0.110* Prior documented Poisoning 
history – 0.077* Alcohol – 0.111 * Psychosis 
 
 
 
TABLE 9: Asthma Model Predictors. 
A NOVA 
Model 
Sum of 
Squares df 
Mean 
Square F Sig. 
 Regression 28.212 10 2.821 14.007 .000l 
Residual 124.674 619 .201   
Total 152.886 629    
a. Predictors: (Constant), INHALATION 
b. Predictors: (Constant), INHALATION, P_POISON_HIS 
c. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine 
d. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender 
e. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA 
f. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA, 
Hist.D.A 
g. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA, 
Hist.D.A, DERMAT 
h. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA, 
Hist.D.A, DERMAT, Age 
i. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA, 
Hist.D.A, DERMAT, Age, DIABETES 
j. Predictors: (Constant), INHALATION, P_POISON_HIS, Cocaine, Gender, RACE_AA, 
Hist.D.A, DERMAT, Age, DIABETES2, Heroin 
k. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, RACE_AA, Hist.D.A, 
DERMAT, Age, DIABETES2, Heroin 
l. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, RACE_AA, Hist.D.A, 
DERMAT, Age, DIABETES2, Heroin, RECTAL_VAGINAL 
m. Dependent Variable: ASTHMA2 
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TABLE 10: Asthma Regressions’ Model Summary.  
 
Model Summary 
Mode
l 
R R Square 
Adjusted R 
Square 
Std. Error of the Estimate 
1 .242a .059 .057 .480 
2 .304b .092 .090 .472 
3 .336c .113 .109 .467 
4 .365d .133 .128 .462 
5 .390e .152 .145 .457 
6 .401f .161 .153 .455 
7 .411g .169 .160 .453 
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TABLE 10 (Continued): Asthma Regression Model Summary. 
 
a. Predictors: (Constant), INHALATION 
b. Predictors: (Constant), INHALATION, P_POISON_HIS 
c. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender 
d. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, Heroin 
e. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, Heroin, CANCER2 
f. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, Heroin, CANCER2, 
RACE_AA 
g. Predictors: (Constant), INHALATION, P_POISON_HIS, Gender, Heroin, CANCER2, 
RACE_AA, Age 
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TABLE 10 (Continued) Asthma Regression Model’s coeifficients. 
 
h. Dependent Variable: ASTHMA 
Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients t Sig. 
B Std. Error Beta 
 
(Constant) .419 .081  5.158 .000 
INHALATIO
N 
.221 .040 .217 5.579 .000 
P_POISON_H
IS 
.147 .039 .147 3.815 .000 
Gender -.140 .037 -.141 -3.772 .000 
Heroin .149 .039 .143 3.841 .000 
CANCER2 .728 .187 .143 3.884 .000 
RACE_AA .136 .045 .114 2.994 .003 
Age -.004 .001 -.096 -2.481 .013 
a. Dependent Variable: 
ASTHMA2 
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